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SUMMARY 
Parkinson’s disease (PD) is a complex neurodegenerative disorder which affects the 
physical, psychological and functional status of individuals. It is the second most 
common neurodegenerative disease in the world today affecting approximately 8,000 
people in Ireland. The most common motor disturbances related to PD are reduced 
balance and mobility which can lead to a reduction in physical functional 
performance and health-related quality of life.  
Pharmacology is the cornerstone of treatment in PD. However, even with optimal 
medical management people with PD (PwPD) still experience a deterioration in 
functional performance. Research relating to the efficacy of physiotherapy and 
exercise interventions in the management of PD has tripled in the last decade. 
However, uncertainty remains as to which type, intensity and frequency of exercise 
are most beneficial. 
Aims 
The aim of this study is to assess the feasibility of a six week large-amplitude group 
exercise class on physical functional performance in individuals with mild-moderate 
PD. 
Objectives 
To determine if a one hour weekly large-amplitude group exercise class 
incorporating a daily home exercise programme: 
1) Is feasible and safe to carry out both in a hospital setting and a home 
environment as measured with a safety adverse events form. 
2) Improves physical functional performance measures of balance, gait, 
functional mobility and exercise tolerance with mild to moderate PD as 
measured with the Six Minute Walk Test (6MWT), Dynamic Gait Index 
(DGI) and Timed Up and Go (TUAG). 
3) Improves health-related quality of life (HRQOL) using the Parkinson’s 
Disease Questionnaire-39 (PDQ-39). 
4) Yields participant satisfaction as measured with a satisfaction questionnaire. 
5) Facilitates exercise motivation and adherence as measured with a daily home 
exercise logbook.
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Methods 
A pretest-posttest single study pilot design was utilised to address the research 
question. Eligibility criteria included a diagnosis of idiopathic PD, a Hoehn and Yahr 
score of 1-3, independently mobile with or without a gait aid and the ability to give 
informed consent.  
Feasibility outcome measures included safety, exercise compliance, adherence rates, 
retention rates and participant satisfaction. 
The primary clinical outcome measure was the 6MWT. 
Secondary clinical outcome measures of interest included the Movement Disorder 
Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part II and Part 
III, TUAG, DGI and the PDQ-39. 
 
Results 
Large-amplitude group exercise training is both feasible and safe to carry out in an 
acute hospital setting and at home. 
Statistically significant changes in mean scores between T1 and T2 were found for 
the 6MWT (mean change 37.67m, 95% CI (-57.45, -17.89) p=0.01), TUAG and DGI 
and for the motor examination section (Part III) of the MDS-UPDRS. 
Non-significant changes in mean scores between T1 and T2 were found for the ADL 
section (Part II) of the MDS-UPDRS and PDQ-39. 
 
Conclusions and Implications of findings 
A six week large-amplitude group exercise programme is feasible and safe and 
demonstrated significant changes in functional performance outcomes in PwPD. The 
author suggests that a more rigorous study design, that is adequately powered, is 
warranted to evaluate the efficacy of this exercise intervention in PwPD. 
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INTRODUCTION 
Parkinson’s disease (PD) is a complex and highly prevalent neurodegenerative 
disorder characterised by disabling motor abnormalities such as bradykinesia, 
postural instability, and gait disorders that can lead to falls, increased risk of 
fractures, poor quality of life and reduced survival (Lo et al, 2009). Because of its 
unknown cause, dopamine-producing cells in the substantia nigra degenerate which 
are responsible for movement, balance and walking. The diagnosis is primarily based 
on clinical criteria. The clinical hallmarks of PD are tremor, rigidity, akinesia and 
postural instability (de Geode et al, 2001). A recent review showed worldwide 
prevalence rates of PD between 100 and 300 per 100,000 (Dorsey et al, 2007). 
Parkinson’s disease affects approximately 8,000 people in Ireland (Parkinson’s 
disease Association of Ireland 2008).  
The management of PD has traditionally centred on pharmacological treatment, but 
even with optimal medical management, people with PD (PwPD) still experience a 
deterioration of body function, activities of daily living (ADLs) and participation in 
society. Functional physical performance outcomes such as balance and gait are 
commonly impaired in people with PD (PwPD) and are a major contributor to 
increased disability and decreased health-related quality of life (HRQOL) (Nicolien 
et al, 2013). This can lead to an increased dependence on others, depression, isolation 
and inactivity. The symptoms and physical impairments associated with PD make 
PwPD about one third less active than older adults without PD (van Nimwegen et al, 
2011). Animal studies have shown that reduced physical activity may contribute to 
neuro-degeneration (Tilerson et al, 2002). However, exciting advances in 
neuroscience research have suggested that exercise induces neurochemical and 
13 
 
neuroplastic changes, which contributes to neuroprotection for the brain (Fisher et al, 
2008).  
There is a growing evidence base for exercise and physiotherapy interventions for 
PwPD (Tomlinson et al, 2012; Keus et al, 2014). The recent European Physiotherapy 
PD Guidelines (2014) recommended three modalities of care to target impairments 
and activity limitations experienced by PwPD. These include movement strategy 
training, practice and exercise. Exercise addresses physical capacity and functional 
mobility, focussing on balance, transfers and gait related activities.   
One particular novel exercise intervention which is gaining increased attention in the 
literature and is recommended in the European Physiotherapy PD Guidelines (2014) 
is the Lee Silverman Voice Training (LSVT) BIG (Farley et al, 2005). This exercise 
intervention uses a goal of intensive large-amplitude movement training combined 
with functional mobility training delivered in individual treatment sessions four 
times a week for four weeks (Ebersbach et al, 2010). However, this intense, 
individualised training programme could be a barrier for adherence for PwPD and is 
extremely demanding on hospital resources and expensive for the Health Service 
Executive (HSE) to administer. Another large-amplitude programme that is currently 
being developed is the Parkinson’s Wellness Recovery (PWR!) Programme 
(Krasteva et al, 2015) however, no randomised controlled trials (RCTs) have been 
conducted to establish its efficacy. The key difference between this programme and 
LSVT BIG is that PWR! incorporates group exercise into their programmes whereas 
LSVT BIG are very strict in maintaining individualised programmes.  A group 
delivery format would significantly reduce the cost to implement making it more 
economically viable to deliver compared to individually delivered programmes.  
14 
 
Group exercise programmes have demonstrated positive improvements relating to 
functional mobility and health-related quality of life (HRQOL) in PwPD (Sage et al 
2009). It is suggested that the benefits of group exercise programmes result from a 
combination of the physical intervention, social interactions and motivation of the 
group environment (Crizzle et al, 2005). The feasibility and efficacy of a large-
amplitude group exercise training programme administered once a week over a 
shorter time period (six weeks) has yet to be investigated. 
PD is a chronic progressive neurological condition with individuals facing an 
inevitable increasing disability and reduced activity. Despite a dramatic increase in 
research relating to exercise and PD, uncertainty prevails in the literature regarding 
optimal frequency, dose and intervention type (Keus et al, 2014). Physiotherapists 
play a vital role in delivering evidenced-based exercise interventions. Therefore, 
ongoing research is required into novel exercise interventions to assist with finding 
solutions to these unanswered questions. 
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CHAPTER 1                          LITERATURE REVIEW 
 
1.1 Overview of Aetiology of Parkinson’s Disease 
Parkinson’s Disease (PD) is a complex neurodegenerative disorder which affects the 
physical, psychological and functional status of individuals (Goodwin et al, 2008). 
Dopamine-producing cells in the substantia nigra progressively degenerate, affecting 
the control and regulation of movement, balance and walking (European Guidelines, 
2014). Based on emerging evidence about the pathological changes, Stern et al 
(2012), have proposed a theory on the different stages involved in PD. The authors 
outlined three distinct stages of the disease process as the preclinical, premotor and 
motor stages. Motor symptoms indicate an advanced disease process. Rating scales 
are widely used in clinical practice and research to track disease progression. The 
Hoehn and Yahr (H&Y) rating scale is the most established which ranges from zero 
(no symptoms) to five (unable to walk) (Hoehn and Yahr, 1967). Mild to moderate 
PD represents stages zero to three on the H&Y scale. 
 
1.1 Signs and Symptoms of Parkinson’s Disease 
The signs and symptoms associated with PD are described in the categories of motor 
and non-motor symptoms. The cardinal motor signs of PD are resting tremor, 
bradykinesia, rigidity and postural instability. Motor disturbances related to PD can 
cause a decline in balance and mobility leading to a reduction in physical functional 
ability (Muslimovic et al, 2008). Non-motor symptoms such as depression, olfactory 
dysfunction and impaired executive function can be detrimental to health-related 
quality of life (HRQOL) of individuals (Martinez-Martin et al, 2011). 
16 
 
1.2 Treatment in Parkinson’s Disease 
Medication is the first treatment choice in care for people with PD (PwPD). The 
largest advance in symptomatic management of rigidity, bradykinesia and tremor 
was the development of levodopa, a dopamine precursor that replaces the lost 
dopamine in the brain (Dunnett and Bjorklund, 1999). Levodopa is regarded as the 
gold standard in treatment of PD (Katzenschlager et al, 2008). 
 
In addition to medication, neurosurgery is an option for some PwPD (Volkmann, 
2007), involving the implantation of a deep brain stimulator into the thalamus, 
globus pallidus or subthalmic nucleus. This can help alleviate motor symptoms. 
 
Even with optimal medical management, PwPD still experience a deterioration of 
body functions, activities of daily living (ADLs) and participation restrictions. This 
can lead to increased dependence on others, inactivity and social isolation, resulting 
in reduced quality of life. Therefore, there is a pressing need for non-medical 
treatment strategies, of which physiotherapy is the most applied and supported by 
scientific evidence (European Guidelines, 2014). Several high quality systematic 
reviews have evaluated the efficacy of physiotherapy and exercise in the 
management of PD (Keus et al, 2007; Tomlinson et al, 2012; Redecker et al, 2014). 
The number of publications addressing exercise for PD has tripled in the past decade, 
resulting in a dramatic increase in the number of exercise strategies available to 
PwPD (Nicolien et al, 2013). 
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1.4 Benefits of Different Exercise Strategies to Optimise Functional Physical 
Performance in PD 
Functional independence and optimal physical performance is related to the capacity 
to perform ADLs independently (Gobbi et al, 2009). Balance and mobility are crucial 
to their performance. There is solid evidence that traditional exercise interventions 
such as balance and treadmill training improves functional ability in PwPD. 
 
1.4.1 Balance Training 
Postural instability is a cardinal feature of PD and distinguishes mild and moderate 
PD (Jacobs et al, 2006). Smania et al (2010) studied the effect of balance training on 
postural instability and found that balance training was superior to general exercise 
for improving balance, balance confidence and reducing number of falls. A meta-
analysis of 16 trials carried out by Allen et al (2011), investigated the effect of 
exercise and motor training on balance and falls in PD. Results revealed that the 
impact of exercise and motor training indicated significantly improved balance-
related activity performance especially involving programmes which included highly 
challenging balance training. However, the difference in effect sizes was not 
statistically significant (p=0.16). A Cochrane review of 39 trials found similar results 
to the above meta-analysis, where significant improvements in balance were 
achieved with physiotherapy. Despite this, it had no effect in decreasing the number 
of falls compared to no treatment (Tomlinson et al, 2013). Further research is 
required to inform therapists of the best method of balance training, its optimal 
dosage and its impact on falls rates. 
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1.4.2 Treadmill Training 
The European Physiotherapy Guidelines (2014), reported strong recommendations 
for the use of treadmill training to improve walking speed and stride length and 
conveyed weak recommendations regarding walking distance and balance capacity. 
A Cochrane review of 10 trials supported recommendations for improved walking 
speed and stride length (Mehrholz et al, 2010). Treadmill training was also found to 
be a safe and feasible rehabilitation option (Herman et al, 2009). A recent 
randomised controlled trial (RCT) of 67 participants found that low intensity 
treadmill training (50 minutes at 40%-50% of heart rate reserve) was more effective 
than high intensity treadmill training (30 minutes at 70%-80% of heart rate reserve) 
for increasing walking capacity (Shulman et al, 2013). However, the results of this 
trial are only generalisable for people with mild to moderate PD and should be 
implemented into clinical practice with caution for people with moderate to advanced 
PD. Numerous trials failed to report any adverse events on the use of treadmill 
training which impacts on the methodological rigour of these studies. 
 
Given the complex nature of PD-specific deficits that contribute to poor balance and 
gait, it is unlikely that one specific exercise type alone, such as balance or treadmill 
training, will necessarily improve physical performance adequately. There is a 
growing evidence-base investigating multifaceted exercise interventions such as Tai 
Chi (Hackney and Earhart, 2008), sensorimotor agility training (King and Horak, 
2009) and dance (de Dreu et al, 2012) to target multiple aspects of disability.  
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1.4.3 Dance 
Dance is receiving increased attention in the literature as it combines strategies from 
single exercise intervention types such as cueing, balance, strength, flexibility and 
aerobic exercise to form an interesting and enjoyable exercise strategy. As dance 
requires high-level multitasking and progressive motor skill learning, it is both 
physically and cognitively challenging (Duncan et al, 2012). Dance aims to improve 
gait, balance and mood (de Dreu et al, 2012). A wide range of international dance 
techniques have been researched, from American ballroom (Hackney and Earhart, 
2009) to Argentine tango (Foster et al, 2013) to Irish set dancing (Volpe et al, 2013). 
The music provides an external rhythm, which can be considered as auditory cueing.  
However, dance may induce falling as it involves backward stepping. Therefore, the 
European Physiotherapy Guidelines for PD (2014) advise caution when selecting 
PwPD for tango classes. The therapist must employ sound clinical judgement, and if 
indicated must adapt the steps to the individuals’ impairments and activity 
limitations. Irish set dancing is deemed a safe and acceptable intervention (Volpe et 
al, 2013).  
 
1.5 Exercise Intervention Components required for Neuroplastic Changes and 
Functional Physical Improvements 
In addition to the benefits of traditional and multifaceted exercise interventions, there 
is emerging evidence indicating that exercise may also exert disease modifying 
effects in PD. This can be through neuroprotection or neurorestoration.  
There is strong evidence from animal studies that aerobic training not only improves 
functional performance but also creates changes at the level of the brain itself. 
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Experimental rodent models of PD showed that high-intensity aerobic training 
increased postsynaptic D2 receptor mRNA expression and binding affinity, down 
regulated the dopamine transporter protein and reduced glutamate transmission and 
synaptic strength (Petzinger et al, 2010). Moreover, in both the 6-hydroxydopamine 
(6-OHDA) lesioned rat and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MDTP) which is a neurotoxin precursor that causes permanent symptoms in PD, 
high intensity treadmill training running, initiated before, during or after 
neurotoxicant exposure, showed an improvement in motor symptoms (Petzinger et 
al, 2007; Tillerson et al, 2013).                                                                           
 
Neurochemical and neuroplastic changes are less straightforward when studying 
exercise interventions for humans. Nevertheless, a translational pilot study was 
recently published in which intensive aerobic exercise in four patients with early PD 
resulted in better postural control and increased postsynaptic D2 receptor binding 
potential on positron emission tomography (PET) imaging (Fisher et al, 2013). 
Functional magnetic resonance imaging (MRI) performed after a single bout of 
forced exercise revealed the same change in network activation pattern as that seen 
between medication states (Alberts et al, 2011). Similar results were observed in 
PwPD with transcranial magnetic stimulation after high-intensity treadmill training, 
whereby reduced cortical hyperexcitability (which is characteristic for the 
parkinsonian state) was found (Fisher et al, 2008).  
 
Another indirect measure of neuroplasticity in dopaminergic signalling can be 
provided by changes in the levodopa-equivalent dose. One randomised controlled 
21 
 
study reported that a four week inpatient rehabilitation programme of 50 participants 
resulted in a long-lasting decrease in medication usage over a two year period 
(Frazzitta et al, 2012). These findings suggest that the natural worsening of 
symptoms associated with PD can be effectively counteracted by a properly designed 
intensive rehabilitation programme. However, further studies are warranted in this 
area to substantiate these results.  
 
Generalisation of motor learning is another way of looking at cerebral motor 
plasticity. Three phases of motor learning are distinguished. Firstly, acquisition 
involves considerable improvement across several sessions of practice. 
Automatisation occurs when skilled behaviour requires minimal cognitive resources 
which are stable of time and resistance to interference such as dual tasking. Finally, 
retention is seen when motor skills are readily executed without further need of 
practice on the task. Even though limited, several studies have shown that PwPD are 
capable of motor learning (Nieuwbower et al, 2009; Rochester et al, 2010). The 
ability to learn a novel skill may be preserved by compensation of the basal ganglia 
dysfunction with activation of other brain structures such as the cerebellum (Pendt et 
al, 2011). The potential for learning is believed to diminish over the disease course, 
whereby the greatest potential for learning may be gained at H&Y stages one to three 
(Abbruzzese  et al, 2009). In general, PwPD benefit from practice, but require an 
augmented training dose and intensity in comparison to their age-matched healthy 
counterparts (Soliveri et al, 1992).  
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1.6 Neuroplasticity-Principled Exercise Interventions that Optimise Functional 
Physical Improvements 
Two novel treatment approaches called Lee Silverman Voice Training BIG (LSVT 
BIG) (Farley et al, 2008) and Parkinson’s Wellness Recovery (PWR!) (Krasteva et 
al, 2015), propose to translate data from animal models of PD to a neuroplasticity-
principled model of rehabilitation for the treatment of human PD (Fox et al, 2012).                                                     
 
LSVT BIG uses training of big amplitude movements, high intensity, sensory 
recalibration, functional mobility training and patient specific salient goals as its 
focus for rehabilitation. It is designed to promote neuroplasticity and neuro-
restoration (Farley et al, 2008; Fox et al, 2012).  The delivery protocol for this 
programme constitutes 16 treatment sessions. The individual receives four 
individualised training sessions a week which is progressed over the course of four 
weeks (Farley et al, 2008). A recent perspective article which included 12 systematic 
reviews and meta-analysis (Nicolein et al, 2013) and the European Physiotherapy 
Guidelines for PD (2014), recommend this exercise approach for targeting gait, 
balance, transfers and physical capacity. 
 
To date, only four studies on the effectiveness of LSVT BIG have been published. 
Farley et al (2005), conducted the first “Training BIG” trial, a noncontrolled study, 
which assessed the effects of two conditions of velocity on walking and reaching 
movements. The methodological quality of this study is severely inadequate. Firstly, 
the trial design is poor. An RCT which is the most scientifically rigorous method of 
hypothesis testing would have enhanced the robustness of this study. Eighteen 
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subjects volunteered to participate in the study, however, there is no reference as to 
why the authors chose this number, nor was a sample size calculation carried out. 
This inadequacy limits the validity of the study. The description of the Training BIG 
intervention is vague which impacts on the study’s reproducibility. None of the 
outcome measures utilised were PD-specific measures which is limiting. However, 
they were tested by blinded examiners which reduces bias to the results. Despite this, 
results revealed that training of amplitude in people with PD resulted in faster upper 
and lower limb movements especially in people with mild PD.  
 
Ebersbach el al (2010), addressed the issue of poor trial design by carrying out the 
first RCT comparing LSVT BIG with Nordic walking and a domestic nonsupervised 
exercise programme. However, the methodology section is poorly described. 
Randomisation was conducted by “drawing lots” to one of the three intervention 
groups. The authors failed to mention vital information regarding the transparency of 
the randomisation process. There was no reference made to sequence generation, 
allocation concealment or who enrolled the participants. As seen in the previous 
study, the authors did not address how their sample size was determined or 
calculated. Thirdly, a bias was evident in favour of the LSVT BIG intervention 
which constituted one-to- one therapy time, whereas, the other interventions were in 
a group or nonsupervised setting. Despite several methodological discrepancies, the 
authors concluded that training LSVT BIG led to a clinically relevant improvement 
in motor performance in the primary outcome measure Unified Parkinson Disease 
Rating Scale (UPDRS-III) and also in secondary outcomes of gait speed and 
distance.  
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The same author conducted an RCT comparing LSVT BIG and a shorter training 
protocol of 10 treatment sessions (Ebersbach et al, 2014). Clinically significant 
results for the UPDRS-III were obtained for both protocols. However, the authors 
recommended that the higher intensity protocol was recommended as it was more 
effective in obtaining patient-perceived benefit. Once again, numerous 
methodological flaws are evident in this study as no changes were made to the 
methodological process from the previous study. The need for improvement of 
methodological quality of trials in physiotherapy for PD is highlighted in various 
systematic reviews (Tomlinson et al, 2012). 
 
Dashtipour et al (2015) conducted a double-blinded RCT assessing the effects of 
LSVT BIG versus a general exercise programme on motor and non-motor symptoms 
of PD. This study did not adhere to numerous CONSORT recommendations which 
impacts greatly on the trial’s methodological quality. In this study, patients were 
randomly assigned to either the LSVT BIG group or the exercise group. No further 
explanation was provided regarding the randomisation method or procedure. An 
extremely small sample size of 11 participants was recruited, with no mention of 
how this sample size was determined. The authors attempted to improve on the bias 
seen in Ebersbach’s work by providing one to one therapy time for both groups. The 
trial was not able to detect a difference between the two exercise groups but showed 
that general exercise was as effective as LSVT BIG therapy in managing motor and 
non-motor symptoms. 
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Numerous limitations of the LSVT BIG programme have been highlighted (Fox et al, 
2012). For example, additional dose-response relationships need to be established 
and also the practical feasibility of delivering 16 sessions in four weeks and for 
clients to be able to commit to this needs to be addressed. 
The author and her colleague had previously carried out an individualised pilot 
LSVT BIG programme on one individual in an acute hospital setting which yielded 
positive outcomes on mobility, balance, dual-tasking and quality of life. However, 
there were numerous barriers to conducting this intensive individualised programme 
which supports the limitations outlined by Fox et al, (2012). The physiotherapy 
manager could not justify another programme to be conducted due to limited staff 
resources. This motivated the author to address a gap in the literature regarding the 
feasibility and efficacy of a group exercise large-amplitude class for people with 
mild to moderate PD.  
 
1.7 Benefits of Group Exercise for People with Parkinson’s Disease 
The European Physiotherapy Guidelines for PD (2014), recommend group exercise 
programmes as an effective mode of exercise delivery. A group delivery format 
significantly reduces both the burden on staffing levels and the cost to implement, 
making it economically viable to be delivered (Rodrigue et al, 2006). Group exercise 
studies in PwPD have shown efficacy in physical performance outcomes, high 
attendance rates and improved mood (Sage et al, 2009). An RCT comparing a home-
based exercise intervention to a combined home and group exercise program over 12 
weeks found that both groups improved their motor function and HRQOL but that 
the combined group had significantly greater improvements, especially in mental 
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health benefits (Helbostad et al, 2004). The positive elements from group 
programmes may be due to the physical exercise, the social interactions, motivation 
of the group environment or a combination of these factors. However, intervention 
delivered in a group format may not be as specific to the needs of the individual 
participant and attention from the instructor is reduced compared to individual 
therapy. One key benefit of group exercise programs is that they resemble the types 
of ongoing community programs that clients will likely participate in after 
completing an acute hospital-based programme (European Guidelines, 2014). 
 
Another innovative neuroplasticity-principled exercise programme that has been 
gaining increased interest by the Movement Disorders Society and the literature is 
the Parkinson’s Wellness Recovery (PWR!) Programme. This programme was 
developed by the co-founder of LSVT BIG and is modelled on the LSVT BIG 
programme. However, the contrasting feature of the PWR! Programme is that it 
incorporates principles of group exercise training into its intervention. Dr. Becky 
Farley who is a co-founder of LSVT BIG opened a PWR! Gym in Arizona in 2012. 
Unfortunately, there has been no RCT carried out to date to determine the efficacy of 
this treatment approach.  Preliminary research, although inadequate in its 
methodology and study design (quasi-experimental pre-post intervention study), 
demonstrated that the PWR! programme resulted in statistically significant increases 
in functional mobility and balance outcomes (p<0.01) as measured by the six minute 
walk test (6MWT), functional gait assessment (FGA) and the  timed up and go test 
(TUAG). However, results were not maintained at a one month follow-up and there 
was an inadequate reporting of adverse events and drop-out rates (Krasteva et al, 
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2015). This author was informed that an RCT incorporating elements of the PWR! 
Programme will be conducted in the immediate future. 
It is clear that the main limitation of the PWR! Programme is the lack of explicit 
research to determine its effectiveness and relevance in clinical practice. 
 
1.8 Conclusion 
Exercise is a proven beneficial adjunct in the management of PD and a wide range of 
exercise interventions are currently being adopted in clinical practice. Emerging 
evidence has demonstrated that neuroplasticity-principled approaches and novel 
restorative rehabilitation interventions such as LSVT BIG and PWR! are yielding 
improvements in functional physical outcomes. However, the number of published 
LSVT BIG trials are scarce and the methodological quality is inadequate. The 
European Physiotherapy Guidelines for PD strongly recommend that 
physiotherapists provide group exercise training for PwPD. It has the combined 
effects of being economically viable, improving physical performance outcomes, 
increasing attendance rates, improving mood and enhancing social engagement. 
Considering that LSVT BIG is an individualised and copyrighted protocol, and that 
PWR! requires additional scientific evaluation, the author proposed to test the 
feasibility and efficacy of a large-amplitude group exercise class adopting principles 
of both LSVT BIG and PWR! programmes. 
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CHAPTER 2                               METHODOLOGY 
2.1 Aims and Objectives 
The aim of this study was to assess the feasibility of a six week large-amplitude 
group exercise class on physical functional performance in individuals with mild-
moderate PD. 
 
Objectives 
To determine if a one hour six weekly large amplitude group-exercise class 
incorporating a daily home exercise programme: 
1) Is feasible and safe to carry out both in a hospital setting and a home 
environment as measured with an adverse events form. 
2) Improves physical functional performance measures of balance, gait, 
functional mobility and exercise tolerance with mild to moderate PD as 
measured with the Six Minute Walk Test (6MWT), Dynamic Gait Index 
(DGI) and Timed Up and Go Test (TUAG). 
3) Improves health related quality of life (HRQOL) using the Parkinson’s 
Disease Questionnaire-39 (PDQ-39). 
4) Yields participant satisfaction as measured with a satisfaction questionnaire. 
5) Facilitates exercise motivation and adherence as measured with a daily home 
exercise logbook. 
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2.3 Study Design 
2.3.1 Study Design 
A pretest-posttest single study pilot design was selected to address the research 
question. The reason for this choice of study design over a quasi-experimental design 
or an RCT, was due to the limited resources and participants available to the 
principal investigator (PI). The Physiotherapy Manager of Naas General Hospital 
(NGH) could not support the time for other members of staff to assist with the 
research study. Also, with a limited number of PwPD on the neurology database in 
the hospital, recruitment was not possible for the larger numbers required for an 
RCT. 
 
2.3.2 Statistical Powering 
A sample size of 24 participants was required to demonstrate a statistically 
significant treatment effect of the intervention. As there is no minimum clinically 
important difference (MCID) for the primary outcome measure of the 6MWT for 
PwPD, the PI utilised a sample size power calculation from a PD quasi-experimental 
study (Lauhoff et al, 2013).  A sample size of 24 was sought to show an increase of 
82 metres (minimal detectable change) on the 6MWT with an α of 5% and a power 
of 80%. 
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2.4 Participants 
2.4.1 Recruitment 
Individuals with mild to moderate PD were recruited from both the outpatient 
neurology waiting list and an established PD review database in NGH. Day Hospital 
patients were excluded from this study as they exhibited moderate to severe 
symptoms of PD. A substantial number of individuals from the PD database had 
attended for physiotherapy intervention and a PD class in the past, however, 
individuals who had received physiotherapy input for PD in the previous three 
months were excluded. The remaining individuals were newly diagnosed and had 
received no previous physiotherapy intervention. All potentially eligible participants 
were sent an invitation letter (Appendix 1) from the Deputy Physiotherapy Manager 
who acted as gatekeeper for the research study, inviting them to participate in the 
research programme. The invitation letter was accompanied by a patient information 
leaflet (Appendix 2) and consent form (Appendix 3) which outlined the purpose and 
nature of the study. The participants had seven days to decide whether they wished to 
participate in the research study. After one week, the PI contacted the potential 
participants by telephone to verify eligibility and to schedule baseline assessment 
appointments. Verbal consent was gained over the phone with formal written consent 
obtained at the baseline assessment. Recruitment took place over six weeks from 
early September to mid-October. 
 
2.4.2 Inclusion and Exclusion Criteria 
Inclusion Criteria: 
 Diagnosis of Idiopathic PD diagnosed by a Consultant Neurologist. 
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 Disease severity measured on the Hoehn and Yahr Scale of 1-3 (Appendix 
4) 
 Independently mobile with or without a gait aid. 
 Ability to give informed consent and follow simple commands. 
Exclusion Criteria: 
 Diagnosis of Non-Idiopathic PD. 
 Unstable cardiovascular disease. 
 Uncontrolled chronic condition including rheumatological and 
musculoskeletal conditions 
 Confirmed diagnosis of a dementia or a PD related dementia. 
 Any previous physiotherapy input for PD in the previous three months. 
 
2.5 Ethical Considerations 
2.5.1 Ethical Approval 
Ethical approval was obtained from the Research Ethics Committee (REC) in NGH 
on the 29
th
 June 2015 (Appendices 5 & 6). The Royal College of Surgeons of Ireland 
REC accepted the ethical approval granted by NGH for this study on the 1
st
 
September 2015; REC1118 (Appendix 7). 
 
2.5.2 Ethical Issues 
2.5.2.1 Informed Consent 
The ability to give informed consent was stipulated in the inclusion criteria. Verbal 
consent was gained over the phone when the PI contacted potentially eligible 
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participants. Written consent (Appendix 3) was obtained at the baseline assessment 
meeting. 
The patient information leaflet clearly outlined that no individual was under any 
obligation to partake in the research study. Participation was voluntary and 
participants had the opportunity to withdraw at any time. The routine management of 
those who did not wish to participate or those who withdrew from the class was not 
affected in any way. 
 
2.5.2.2 Confidentiality 
Confidentiality of participants’ identity was maintained throughout the course of the 
study. Appropriate measures were undertaken to ensure confidentiality of the 
collected data. All participants were provided with a unique identifier number. This 
was kept in a separate file and location to the hard data and electronic data. Only the 
PI had access to the “key” to these codes. All electronic data was coded and stored 
on the PI password protected computer in the physiotherapy department. The hard 
copy records of data were stored in a locked filing cabinet in the physiotherapy 
department in NGH. 
 
2.5.2.3 Safety Considerations 
As with any exercise intervention, there is a very small risk of falls or injury, 
however, the participants were supervised at all times and an environmental risk 
assessment was conducted as per usual care prior to each class. Group exercise 
classes are part of routine care for this cohort of patients. 
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2.6 Assessments 
To minimise the possibility of assessor bias and a threat to instrument internal 
validity, a blinded assessor carried out baseline and post intervention assessments. As 
the Physiotherapy Manager could not support physiotherapy staff to carry out the 
assessments, a Universtiy College Dublin (UCD) undergraduate student, who was 
under the guidance of a hospital clinical tutor, was selected to act as blinded assessor. 
The same student was granted permission from UCD to return to NGH and carry out 
the post intervention assessments. Appropriate instructions and training for 
undertaking the outcome measures was provided by the PI. Assessments were carried 
out in the physiotherapy gym in NGH and took approximately 30-35 minutes to 
complete. Pre and post intervention assessments were carried out at the same time 
and on the same day to ensure consistency with the timing of medication dose and 
assessment time. This is in keeping with recommendations from research stating that 
there is an under-reporting from authors about medication and assessment timing, as 
true results may not be obtained if consistency is not adhered to (Kwakkel et al, 
2007).  
 
2.7 Outcome Measures 
2.7.1 Feasibility Outcome Measures 
A feasibility study is a small study for helping to design a further confirmatory study 
(Arnold et al, 2009). Thebane et al (2010) recommend that the outcome measures 
cited below are utilised when conducting feasibility studies. 
1) Safety: This was monitored using weekly adverse events forms both during 
the exercise class and for participants to fill out at home (Appendix 8 and 9). 
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2) Exercise Compliance: This was assessed by monitoring the weekly 
compliance of the participants home exercise logbook (Appendix 10). 
3) Adherence Rates: This was evaluated using weekly attendance records 
(Appendix 11). 
4) Retention Rates: This was evaluated by comparing the proportion of 
participants who attended for baseline assessments against the proportion of 
participants who attended for post intervention assessment. 
5) Participant Satisfaction: This was evaluated using a non-validated satisfaction 
questionnaire that was specifically design for the research study (Appendix 
12). 
 
2.7.2 Clinical Outcome Measures 
A variety of outcome measures that addressed the disability associated with PD at all 
levels of the International Classification of Functioning, Disability and Health (ICF) 
framework (Gubella and Andrew, 2002), were used in this study. 
 
2.7.2.1 Primary Outcome Measure 
The primary outcome measure used in this study was the 6MWT which is a validated 
tool used to measure gait and exercise tolerance (American Thoracic Society, 2002) 
(Appendix 13). It reflects aerobic endurance, speed, balance and agility during 
ambulation (Garber and Friedman, 2003). It measures the maximal distance that a 
patient can walk at a self-paced speed, on a flat hard surface during a six-minute 
period. Participants were required to walk up and down a 10 metre corridor, 
incorporating the important functional component of turning during the assessment 
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(Morris et al, 2001). The number of lengths completed was recorded, along with any 
additional distance covered at the end of the assessment. The 6MWT has been shown 
to have excellent test-retest reliability for PwPD, with an interclass correlation 
coefficient of 0.96 (Steffen and Seney, 2008). Unfortunately, there is no MCID or 
cut-off score established for this population. In a systematic review carried out by 
Tomlinson et al, (2012) the authors considered that a 13 metre increase in distance 
would probably be of clinically importance. However, it must be emphasised that 
this is only an educated opinion and that caution must be exercised when interpreting 
this information. A minimal detectable change (MDC) of 82 metres is established 
(Steffen and Saney, 2008). 
 
2.7.2.2 Secondary Outcome Measures 
Impairment 
2.7.2.2.1 Movement Disorder Society-Unified Parkinson Disease Rating Scale 
Part II and III (MDS-UPDRS II & III)  
The MDS-UPDRS is a common PD research tool that is used to assess the severity of 
motor symptoms (Goetz et al, 2008) (Appendix 14). It consists of four sections, 
whereby separate sections are commonly analysed in research (Goetz et al, 2008). In 
this study, part two (motor impact of experiences of daily living) and part three 
(motor examination) were measured. This scale has high internal consistency and 
high correlation with the original UPDRS scales. It has no established standard error 
of measurement, MDC, MCID or cut-off scores despite being recommended as the 
gold standard outcome measure for PD in research. However, normative data is 
available for the four separate sections (Goetz et al, 2008). 
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Activity Limitations 
2.7.2.2.2 Timed Up and Go Test (TUAG) 
The TUAG (Appendix 15) has been identified as a reliable and valid test of 
functional mobility in the elderly (Podsiadlo and Richardson, 1991) and has been 
shown to have both excellent test-retest reliability and inter-rater reliability when 
used with PwPD (ICC=0.99) (Morris et al, 2001). It requires an individual to stand 
up from a chair, walk a distance of three metres, turn around, walk back to the chair 
and sit down again. The time taken to complete this task is recorded with a stopwatch 
in seconds. However, there is ambiguity in the literature regarding its MDC. Dal 
Bello-Haas et al (2011) reported 4.85 seconds whereas, Steffen & Seney (2008) 
reported 11 seconds. This ambiguity may be attributed to the higher mean age and 
disease severity in the second study. This is a useful tool for predicting falls risk in 
the PD population with a cut-off score of 11.5 seconds (Nocera et al, 2013). 
 
2.7.2.2.3 Dynamic Gait Index (DGI)  
The DGI assesses an individual’s ability to modify balance while walking in the 
presence of external demands (Appendix 16). A maximum score of 24 points can be 
achieved. Eight tasks are assessed; steady state walking, walking with changing 
speeds, walking with head turns both horizontally and vertically, walking while 
stepping over and around obstacles, walking while stepping over and around 
obstacles and finally pivoting while stair climbing. It has an adequate discriminative 
ability between fallers and non-fallers based on a cut-off score < 19 (sensitivity = 
0.64, specificity = 0.85) (Dibble et al, 2008). A MDC of 2.9 points has been 
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established (Huang et al, 2011). The DGI has been recommended for use by the 
European Physiotherapy Guidelines for PD (2014) for dynamic balance assessment.  
 
Participation Restriction 
2.7.2.2.4 Parkinson’s Disease Questionnaire-39 
The PDQ-39 is a well-established and validated questionnaire that is used to evaluate 
the aspects of function and well-being that can be adversely affected by PD (Peto et 
al, 1998) (Appendix 17). The questionnaire includes 39 questions and involves 8 
different dimensions. A total score of 156 can be achieved. A higher score indicates 
an increased impact of PD symptoms. The dimensions include mobility (10 items), 
activities of daily living (6 items), emotional well-being (6 items), stigma (4 items), 
social support (3 items), cognition (4 items), communication (3 items) and bodily 
discomfort (3 items). The Single Index Score (SI) indicates a global impact of PD 
symptoms on quality of life. The questionnaire is intended to be a self-completed 
instrument (Jenkinson et al, 1998).  The PDQ-39 has been shown to have satisfactory 
internal consistency and reliability of the eight dimensions (Peto et al, 1995). 
Jenkinson et al, (1997) showed that internal consistency remains high. The MCID 
and normative data for each subsection have been established for this cohort group 
(Peto et al, 2008).   
 
2.8 Intervention 
The large-amplitude group exercise programme involved attendance of participants 
at one class a week for six weeks in the physiotherapy gym in NGH. The treatment 
38 
 
intervention lasted one hour and participants were encouraged to exercise at a high 
intensity (between 13-17 on the BORG Scale) for the duration of the class. The 
format of the class consisted of a warm up period, large-amplitude stretches, large-
amplitude functional exercises, large-amplitude walking, and a cool down period. 
The PI conducted the exercise intervention. Exercises were progressed weekly in 
terms of intensity, frequency, speed and complexity. In this way, the exercise 
programme adhered to several key principles which are shown to enhance 
neuroplasticity in PD (Fox et al, 2006). The PI provided constant verbal feedback to 
encourage participants to use large amplitude movements for the duration of the 
class. Family members were permitted and encouraged to attend the class to ensure 
that the correct exercise technique was carried over at home. The European 
Physiotherapy Guidelines for PD (2014), recommend involving family members 
with goal planning and intervention sessions. Participants were also instructed to 
complete a daily home exercise logbook. Appropriate resources such as an exercise 
photo pack (Appendix 18), an exercise DVD and a YouTube video link (Appendix 
19) were provided to assist with exercise motivation and compliance.. A maximum 
of six participants took part in each class. 
 
2.9 Statistical Methods 
2.9.1 Data Collection 
A data collection form was developed by the PI to record demographic details such 
as medical history, medications, functional status, falls history and previous 
physiotherapy treatment for PD. A list of the feasibility outcomes and a clinical 
39 
 
outcome measurement table was attached at the bottom of the form. The blinded 
assessor completed this section of the form (Appendix 20). 
 
2.9.2 Statistical Analysis 
Descriptive statistics were used to describe baseline demographic information and 
feasibility measures. To establish if there was a significant difference in clinical 
scores from pretest to post-test assessments, a paired t-test was used to assess 
parametric data and a Wilcoxon signed-rank test was used to evaluate non-parametric 
data. Statistical Package for the Social Sciences (SPSS) Version 22 software package 
was used for statistical analysis. 
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CHAPTER 3   RESULTS 
3.0 Introduction 
The aim of this study was to assess the feasibility of a six week large-amplitude 
group exercise class on physical functional performance in individuals with mild-
moderate Parkinson’s Disease (PD). The objectives were to determine if this 
programme which incorporated an intensive home exercise programme (HEP) is 
feasible and safe to conduct in an acute hospital and in the participant’s home, 
improve functional mobility and balance, yield satisfaction and thus improve health-
related quality of life (HRQOL). 
The feasibility outcomes measures of interest were: 
1) Safety: Monitored using adverse events forms in hospital and at home. 
2) Exercise Compliance: Evaluated completion of daily exercise logbooks. 
3) Adherence Rates: Evaluated weekly attendance records. 
4) Retention Rates: Evaluated the proportion of participants who attended for 
post assessment against the proportion who attended for baseline assessment. 
5) Satisfaction: Evaluated using a non-validated satisfaction questionnaire. 
The primary clinical outcome measure was the Six Minute Walk Test (6MWT). The 
secondary clinical outcome measures of interest were: 
1) Movement Disorder Society-Unified Parkinson’s Disease Rating Scale 
(MDS-UPDRS Part 2 (motor experiences of daily living ADLs) and Part 3 
(motor examination). 
2) Timed Up and Go Test (TUAG). 
3) Dynamic Gait Index (DGI). 
4) Parkinson’s Disease Questionnaire-39 (PDQ-39). 
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3.1 Screening and Eligibility 
3.1.1 Screening 
Recruitment took place from early September 2015 to mid-October 2015. In total, 35 
individuals were invited to participate in the research study. Nine individuals 
declined to participate with reasons displayed in Figure 3.1. 
3.1.2. Excluded Participants 
Two participants were excluded as they did not fulfil the eligibility criteria. This was 
due to uncontrolled chronic musculoskeletal and psychiatric conditions. Two 
participants required one-to-one intervention due to a background of intellectual 
disability.  
3.1.3. Withdrawal and Drop-Outs Prior to the Study 
One participant agreed to participate but declined the day before commencement of 
the study.  
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Figure 3.1 Participant Flow Diagram 
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3.2 Baseline Characteristics of Participants 
This section contains baseline descriptions of the 18 participants who completed post 
intervention assessments. 
3.2.1 Gender 
The study sample consisted of 13 males and 5 females. 
3.2.2. Age 
The mean age of the group was 69.17 years with a standard deviation (SD) of 7.91 
years (range 56 to 83 years). The median age of the group was 72 years with an 
interquartile range of 13 years. 
Figure 3.2: Age Statistics  
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3.2.3 Months since Diagnosis 
The mean number of months since diagnosis was 74.22 with a SD of 55.96 months. 
The range varied significantly from 6 months to 19 years. 
Figure 3.3 Months since diagnosis 
3.2.4 Hoehn and Yahr Scale 
Disease severity ranged from one to four on the Hoehn and Yahr (H&Y) PD rating 
scale. The mean H&Y score was 1.78 with a SD of 1.01. Table 3.1 describes the 
group in more detail. 
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Table 3.1 Hoehn and Yahr Scale 
Hoehn and Yahr Stage Number of Participants (%) 
1 10 (55.5%) 
2 3 (17%) 
3 4 (27.5%) 
 
3.2.5 Medication 
All participants were taking PD specific medication (Figure 3.4) with the majority of 
participants on a form of levodopa therapy (85%).  
MAO-B: Monoamine oxidase-B. COMT:  Catechol-O-methyl transferase  
Figure 3.4 Use of PD specific medication in the study sample 
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3.2.6 Mobility Status 
All participants were independently mobile. The majority of participants did not 
require any walking aid (88.88%). One participant who score a 3 on the H&Y Scale 
used a three-wheeled walker (6.11%) and one participant used a walking stick 
(6.11%) to aid their mobility. 
 
Figure 3.5 Mobility Status 
3.2.7 History of Falls in the six months prior to the study 
A small minority of participants sustained a fall in the six months prior to 
commencing the study, whereby two participants (11%) reported sustaining one fall 
and one participant (5.5%) had sustained two falls.  
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3.3 Baseline Outcome Measures 
The baseline outcome measures were administered by a third year physiotherapy 
student who was blinded to the study. The student had no affiliation to the study and 
all participants’ names were anonymous. The baseline descriptive statistics of the 
outcome variables are presented in Table 3.2 below. 
Table 3.2 Baseline Outcome Measures 
Outcome Measure Study Group 
 Mean SD Range Median IQR 
6MWT (metres) 367.61 88.63 227-546 361.00 102 
MDS-UPDRS 2 (0-52) 10.70 4.84 1-22 11.50 6 
MDS-UPDRS 3 (0-132) 23.44 14.13 8-58 23.50 13 
TUAG (secs) 9.14 2.60 5.59-15.22 8.99 3.02 
DGI (0-24) 19.50 2.98 14-24 20.00 5 
6MWT: Six Minute Walk Test, MDS-UPDRS 2: Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale (ADL Section), MDS-UPDRS 3: (Motor 
examination Section).TUAG: Timed Up and Go Test, DGI: Dynamic Gait Index. 
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3.3.1 Parkinson’s Disease Questionnaire-39 
The PDQ-39 is a self-reported PD questionnaire of HRQOL. The baseline measures 
of each subsection and the index score are described in Table 3.3 below. 
Table 3.3 Baseline Parkinson’s Disease Questionnaire-39 
PDQ-39 
(0-156) 
Study Group 
 Mean SD Range Median IRQ 
Mobility 
(/40) 
14.86 13.30 0-40 12.50 21.30 
Activities of Daily Living 
(/24) 
18.71 10.99 0-41.60 16.60 9.40 
Emotions 
(/24) 
12.93 13.85 0-41.60 6.20 21.90 
Stigma 
(/16) 
7.30 14.58 0-62.50 3.12 7.81 
Social Support 
(/8) 
8.78 23.41 0-100 2.88 6.25 
Cognition 
(/16) 
17.70 13.94 0-50 15.56 20.36 
Communication 
(/12) 
10.62 10.61 0-33.33 8.30 18.70 
Body Discomfort 
(/12) 
23.57 17.67 0.66.66 16.66 27.10 
Parkinson’s Disease 
Summary Index 
 
14.27 8.82 1-30.60 12.35 12.25 
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3.4 Post Intervention Outcome Measures 
3.4.1 Feasibility Outcome Measures 
3.4.1.1 Safety 
Weekly adverse events forms were completed by the Principal Investigator (PI) for 
the six week large-amplitude group exercise programme. Adverse events constituted 
any undesired outcome resulting from the large-amplitude training such as sustaining 
a fall, injuring a limb, laceration, pain and muscle soreness. No participant (0%) 
reported or sustained any adverse events as a result of carrying out the exercise 
programme in the acute hospital setting. Participants completed daily adverse events 
forms at home while carrying out their large-amplitude HEP. Results were calculated 
by measuring the number of adverse events reported over the total number of 
exercises logged in the exercise logbook. Table 3.4 displays these results. 
Table 3.4 Adverse events carrying out the exercise programme at home 
No of Participants (n=18) Adverse Events Reported 
10 0 (0%) 
5 20% (Muscle Soreness) 
3 10% (Muscle Soreness) 
 
3.4.1.2 Exercise Compliance 
Exercise compliance encompassed compliance in completing both the daily home 
exercise logbook and daily use of the exercise resource pack (Photo pack, DVD and 
YouTube link). These were reviewed weekly by the PI. Results are displayed in 
Figures 3.6 and 3.7.  
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Figure 3.6 Compliance completing Home Exercise Logbook                                                           
Level of Compliance: Excellent=>80%, Very Good=70-80%, Good=60-70%, 
Satisfactory=50-60%, Poor=40-50%   
                                                                                                                                            
   
                                                                                                                                                   
Figure 3.7 Compliance utilising the Exercise Resource Pack                                                
Level of Compliance: Excellent=>80%, Very Good=70-80%, Good=60-70%, 
Satisfactory=50-60%, Poor=40-50% 
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3.4.1.3 Adherence Rates 
The mean number of classes attended by the study group was five. Attendance 
ranged from three to six classes. Figure 3.8 elaborates further on adherence rates. 
 
Figure 3.8 Adherence Rates 
3.4.1.4 Retention Rates 
Twenty-one participants completed baseline assessments. Three participants had to 
withdraw during the course of the study due to medical and pre-existing 
musculoskeletal issues. Of the eighteen participants who completed the remaining 
classes 100% attended for post-treatment assessments. 
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3.4.1.5 Satisfaction 
Table 3.5 Satisfaction Questionnaire of six week large-amplitude exercise class 
Question 
%                                 
Strongly 
Disagree 
Disagree 
 
Neither 
Agree or 
Disagree 
Agree 
 
Strongly 
Agree 
 
I found the programme beneficial 0 0 0 44.44 55.56 
I found the frequency of the class 
adequate (x1/week) 
5.55 22.22 11.11 50 16.66 
The duration of the class  (1 hour) 
was too long 
16.66 55.55 11.11 11.11 5.55 
After the exercise programme, I am 
able to walk for longer distances 
0 5.55 27.77 44.44 22.22 
After the exercise programme, my 
ADLs such as doing the house chores 
and shopping are easier to manage 
0 11.11 38.88 27.77 22.22 
After the exercise programme, I feel 
steadier on my feet  
0 5.55 22.22 50 22.22 
My mood has improved after 
completion of the programme 
0 5.55 37.77 38.88 22.22 
The exercise resources (Photo-pack, 
DVD, YouTube link) motivated me 
to exercise at home 
0 5.55 16.66 44.44 33.33 
Please Circle which Resource you 
found most beneficial: 
Photo-
Pack 
          
5.55 
DVD 
 
50 
YouTube 
Video 
                         
11.111 
 None 
Of the 
Above 
27.77 
 
 
The Home Exercise Programme was 
difficult to carry out at home because 
it was too long to carry out 
33.33 50 5.55 5.55 n/a 
I will continue to practice my daily 
home exercise programme when the 
programme has finished 
n/a n/a n/a 55.55 44.44 
I feel that exercising in a group 
setting is more enjoyable than 
exercising one- to -one 
(physiotherapist and individual) 
n/a 16.66 5.55 38.88 33.3 
I would recommend this exercise 
programme to others 
n/a n/a n/a 33.33 66.66 
My exercise habits are going to 
change after the programme 
n/a n/a n/a 50 50 
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3.4.2 Primary Outcome Measure: Six Minute Walk Test 
The mean score for the 6MWT at baseline (T1) was 367.61 metres (m) with a SD of 
88.64 (range 227-546m). The mean score for the 6MWT at post intervention 
assessment (T2) was 405.28m with a SD of 81.12 (range 250-540m).  
A paired t-test was used to determine if there was a significant difference in the 
change in mean scores from TI to T2 for the 6MWT. This statistical test was utilised 
as the data were normally distributed. 
There was a statistically significant change between T1 and T2 (mean change -
37.67m, SD=39.77, 95% CI, (-57.45, -17.89), p=0.01) for the 6MWT following the 
six week large-amplitude group exercise intervention programme. Figure 3.9 
describes scores at TI and T2 
 
Figure 3.9 6MWT Scores at T1 and T2 for the Study Group 
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3.4.3 Secondary Outcome Measures 
 
3.4.3.1 Impairment MDS-UPDRS 
The MDS-UPDRS is a PD rating scale designed to monitor the burden and extent of 
PD. Two sub-categories of the MDS-UPDRS were used in the study sample. Part 
Two measures self-reported motor experiences of daily living and consists of 13 
items. A maximum score of 52 can be achieved. Part Three measures the motor 
examination and consists of 18 items. A maximum score of 132 can be achieved. 
The mean score for the MDS-UPDRS Part 2 at T1 was 10.67 with a SD of 4.83 
(range 1-22). The mean score for the MDS-UIPDRS Part 2 at T2 was 10.00 with a 
SD of 5.27 (range 1-18).  
A paired t-test was used to determine if there was a significant difference in the 
change in mean scores from TI to T2 for the MDS-UPDRS Part 2. The mean change 
between T1 and T2 was 0.667 with a SD of 5.5, 95% CI, (-1.85, 3.18) and a p value 
of 0.583. This indicates that there was no statistically significant improvement in 
self-reported motor experiences of daily living. Figure 3.10 displays these scores. 
 
Figure 3.10 MDS-UPDRS Part Two scores at T1 and T2 
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The mean score for the MDS-UPDRS Part 3 at T1 was 23.44 with a SD of 14.13 
(range 8-58). The mean score for the MDS-UPDRS Part 3 at T2 was 19.72 with a SD 
of 12.69 (range 4-52).  
A paired t-test was used to determine if there was a significant difference in the 
change in mean scores from TI to T2 for the MDS-UPDRS Part 3.                                                                                               
The mean change between T1 and T2 was 3.72 with a SD of 6.99, 95% CI, (.244, 
7.2) and a p value of 0.04. This indicates that there was a statistically significant 
improvement with a p-value of <0.05. Figure 3.11 displays MDS-UPDRS Part 3 
scores at T1 and T2. 
 
 
Figure 3.11 MDS-UPDRS Part Three scores at T1 and T2 
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3.4.3.2 Activity Limitations 
3.4.3.2.1 Timed Up and Go Test 
The standard version of the TUAG test was included in this study. The median score 
for the TUAG in seconds at T1 was 8.99 with an interquartile range (IRQ) of 3.2 
(range 5.59-15.22secs). The median score for the TUAG at T2 was 7.63 with an IRQ 
of 3.7 (range 5.12-14.97secs).  
A Wilcoxon-signed rank test was used to determine if there was a significant 
difference in the change in median scores from TI to T2 for the TUAG as data were 
not normally distributed. 
The median change between T1 and T2 was p<0.01 which implies that there was a 
significant difference between T1 and T2 as a result of the intervention. 
 
Figure 3.12 TUAG Scores at T1 and T2 for the Study Group 
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3.4.3.2.2. Dynamic Gait Index 
The DGI assesses an individual’s ability to modify balance while walking in the 
presence of external demands. A maximum score of 24 can be achieved with a higher 
score indicating enhanced balance performance.  
The median score for the DGI at T1 was 20 with an IRQ of 5 (range 14-24). The 
median score for the DGI at T2 was 22.5 with an IRQ of 4 (range 14-24).  
A Wilcoxon-signed rank test was used to determine if there was a significant 
difference in the change in median scores from TI to T2 for the DGI.   
The median change between T1 and T2 was p<0.01 which implies that there was a 
significant difference between T1 and T2 as a result of the intervention.   
 
Figure 3.13 DGI Scores at T1 and T2 for the Study Group 
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Summary of Outcome Measures at T2 
 
Table 3.6 displays the change in mean or median scores between groups from T1 to 
T2 and the subsequent p-values and 95% Confidence Intervals (where indicated). 
 
Table 3.6 Change in score from T1 to T2 
Outcome 
Measures 
Mean (SD) 
change scores 
from T1-T2 
Median (IRQ) 
change scores 
from T1-T2 
95% CI P Value 
6MWT -37.67 (39.77) N/A -57.45,-17.88 0.01 
MDS-UPDRS 2 0.667 (5.05) N/A -1.85,3.12 0.58 
MDS-UPDRS 3 3.72 (6.99) N/A .244,7.20 0.04 
TUAG N/A =0 N/A 0.01 
DGI N/A =0 N/A 0.01 
6MWT: Six Minute Walk Test, MDS-UPDRS 2: Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale (ADL Section) Part 3 (Motor 
examination), TUAG: Timed Up and Go Test, DGI: Dynamic Gait Index 
 
3.4.3.3 Participation: Parkinson’s Disease Questionnaire 39 
Both a paired t-test and the Wilcoxon-signed rank test were utilised to determine if a 
significant difference in mean and median scores existed between T1 to T2 for the 
PDQ-39 as data in the subsections were both normally and not normally distributed.                                                                                      
There were no statistically significant differences in the change in mean and median 
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scores for all subsections of the PDQ-39. This also held true for the PDSI. Table 3.7 
displays the subsections. 
Table 3.7 Change in score from T1 to T2 for the PDQ-39 
PDQ-39 Mean (SD) 
change 
scores from 
T1-T2 
Median 
(IRQ) 
change 
scores from 
T1-T2 
95% CI P Value 
Mobility N/A =0 N/A 0.14 
Activities of Daily 
Living 
-.46 N/A -5.49,4.56 0.85 
Emotions N/A =0 N/A 0.78 
Stigma N/A =0 N/A 0.41 
Social Support N/A =0 N/A 0.50 
Cognition N/A =0 N/A 0.16 
Communication N/A =0 N/A 0.78 
Bodily Discomfort 0.01 N/A -5.85,5.85 1.00 
Parkinson’s Disease 
Summary Index 
N/A =0 N/A 0.56 
N/A= Not Appropriate. Mean values were used for data that were normally 
distributed, medial values were used for data that were not normally distributed. 
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3.5 Summary of Findings 
Feasibility Outcome Measures: 
 Large-amplitude group exercise training is both feasible and safe to carry out 
in an acute hospital setting and at home. 
 The majority of participants completed their daily home exercise logbook and 
the provision of an exercise DVD was the most popular resource which 
enhanced exercise compliance. 
 The majority of participants found the large-amplitude group exercise class 
very beneficial and would recommend the class to other individuals with PD. 
Primary Outcome Measure: 
 There was a statistically significant change in mean scores in the study group 
between T1 and T2 for the primary outcome measure as measured by the 
6MWT. 
Secondary Outcome Measures:  
 There were statistically significant differences in the change in mean scores 
for the outcome measures pertaining to activity limitations between T1 and 
T2 for the study group as measured by the TUAG and DGI. 
 There was a significant change in mean score for the MDS-UPDRS 3 (motor 
examination) between T1 and T2 for the study group. 
 There was no significant change in mean scores for the MDS-UPDRS 2 
(ADL section) between T1 and T2 for the study group. 
 There were no significant changes in HRQOL between T1 and T2 for the 
study group as measured with the PDQ-39. 
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CHAPTER 4   DISCUSSION 
4.0 Introduction  
Results demonstrated that participation in a six-week, large-amplitude group exercise 
class was feasible and safe to carry out in both an acute teaching hospital and in 
participants’ home environments. This intervention consisted of high intensity, large-
amplitude stretches, large-amplitude functional exercises and large-amplitude 
walking which was progressed weekly in terms of intensity, frequency, speed and 
complexity. A blinded outcome assessor assessed participants at baseline and 
following the six week intervention. Large-amplitude group exercise training was 
found to have a statistically significant beneficial effect on exercise tolerance, 
functional mobility and dynamic balance in a sample of 18 community dwelling PD 
patients. Results also suggest that participation in this intervention led to a significant 
improvement in the motor examination section of the Movement Disorders Society-
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part Three. There was no 
significant change regarding the self-reported motor influence on daily living as 
measured by the MDS-UPDRS Part Two. There was no significant change regarding 
HRQOL as measured by the PDQ-39.  
 
4.1 Results in the context of the current literature 
4.1.1 Feasibility Outcomes 
To the author’s knowledge, this is the first large-amplitude group exercise 
programme that has incorporated principles from both LSVT BIG (Farley et al, 
2005) and PWR! (Krasteva et al, 2015) programmes for people with mild to 
moderate PD.   
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As it was possible that this novel exercise programme may have presented safety 
risks such as injuries or falls, the first aspect of feasibility considered was safety. No 
adverse events occurred carrying out the exercise programme in the acute hospital 
setting. The only adverse event reported from carrying out the programme at home 
was muscle soreness. This could be attributed to the fact a large proportion of people 
with PD (PwPD) are physically inactive (Nicolien et al, 2013) and muscle soreness 
was a direct result of augmented muscle conditioning and exercise. Similar results 
were noted for safety and adverse events in a feasibility RCT of progressive strength 
training and movement strategy training in 210 PwPD in an outpatient clinic 
(McGinley et al, 2012). 
It has been well documented that PwPD are more physically inactive in comparison 
with their age-matched healthy counterparts (Goodwin et al, 2008). Therefore, 
identifying successful methods of getting PwPD to comply with exercise regimes and 
sustaining positive attitudes and behaviours towards exercise is particularly 
important given the growing number of people living with PD in Ireland (Irish 
Parkinson’s Association 2008). Exercise compliance is seldom reported in the 
literature (Thebane et al, 2010). Results in this study demonstrated that the majority 
of participants were either excellent or very good completing their daily home 
exercise logbook, and very good or good utilising their exercise resource pack. It is 
the opinion of the author that daily compliance with the exercise logbook was 
enhanced by the provision of the exercise resource pack (Photo pack, Exercise DVD 
and YouTube Link) especially in the first three weeks of the programme to facilitate 
learning and recall of the new exercises.  
Adherence is a key variable that influences the outcome of a study (Cyarto et al, 
2006), however, few trials of exercise programmes for PD have reported adherence 
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rates (Allen et al, 2010). The mean number of classes attended in this study was five 
out of a total six. The fact that participants saw the benefits of the programme and 
enjoyed attending the class may have influenced good adherence rates (Tomlinson et 
al, 2012). 
A key factor in achieving meaningful results from a study is the ability to retain 
adequate participants. Retaining participants from any older population in a trial can 
be difficult (Wade et al, 2003). Retention rates in this study were very satisfactory at 
100%. Similar satisfactory results were found for progressive strength training and 
movement strategy training whereby, 88% of participants attended for post 
intervention assessment (McGinley et al, 2012).  
Interest is growing in the literature in the systematic evaluation of service delivery 
and the most significant feature of patient care that are likely to influence this is 
patient satisfaction (Cleary et al, 1991). There is no validated questionnaire that 
investigates levels of satisfaction with an exercise programme in PwPD, therefore the 
author developed a satisfaction questionnaire to gain insight into participants’ views 
and opinions regarding the class. Participants in this study were in complete 
agreement regarding the beneficial effects of the programme, recommending the 
programme to other PwPD, continuing the HEP on completion of the six week 
programme and positive behaviour change to exercise post intervention. There was 
less agreement amongst the study sample regarding frequency and duration of the 
class and whether the class improved outcomes such as mood and functional 
outcomes. Interestingly, there was disparity in the group regarding participants’ 
views of group exercise versus 1:1 intervention. Seventy two percent of participants 
found group exercise more enjoyable than 1:1 intervention, however, the remaining 
28% of participants had no opinion or disagreed. The benefits of group exercise in 
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PwPD are well documented in the literature. In a meta-analysis de Goede et al (2001) 
investigated the effects of physical therapy in PD and reported on improvements of 
psychological well-being and the facilitation of several positive behavioural changes 
as additional effects of group exercise. In a systematic review of seven trials that 
investigated the beneficial effects of exercise in PwPD, the authors stated that 
therapy in a group setting helped with enhanced socialisation and provided a 
supportive environment for discussion for PwPD (Crizzle et al, 2006). More recently, 
Nicolien et al (2013), highlighted important considerations for therapists to consider 
when designing exercise programmes. Firstly, safety risks need to be considered as 
an increase in physical activity results in higher incidence of falls and injury in 
PwPD (Hackney and Earhart, 2011). Therapists need to be realistic with the 
timeframe of the class as this influences adherence. It was suggested in the European 
PD Physiotherapy Guidelines that one hour is a reasonable time period. Finally, 
barriers to exercise to as compliance and retention issues need to be addressed and 
therapists need to seek alternative ways to improve exercise participation on a 
permanent basis. The author of this study believes that the above recommendations 
were implemented in this study. 
  
4.1.2. Exercise Tolerance 
Parkinson’s Disease is a progressive neurodegenerative disorder which affects the 
physical, psychological and functional status of individuals (Goodwin et al, 2008). 
People with PD have a tendency towards a more inactive lifestyle (European 
Guidelines, 2014). Compared to their healthy counterparts, people with PD (PwPD) 
are about one-third less active (van Nimwegen et al, 2011). This is in part (24%) 
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predicted by disease severity, gait impairments and limitations in activities of daily 
living (van Nimwegen et al, 2011).                                                        
Parkinson’s Disease is a cause of immobility, and immobility is a cause for the 
progressive loss of exercise endurance and functional aerobic capacity (Delwaide et 
al, 1993). The effect of PD on endurance has been documented by Light et al, (1997) 
where they identified that individuals with moderate to advanced PD walked 
significantly shorter distances than their healthy contemporaries during three 
consecutive two-minute walk tests. The mean distance covered on initial assessment 
in this study was 367.61m. This value increased by 10% to 405.28m following the 
large-amplitude group exercise intervention. This equated to a statistically significant 
improvement of p<0.01. Unfortunately, there are no derived normative data or 
minimal clinically important difference (MCID) values for people with PD for the 
6MWT. Nonetheless, this baseline value  is less than that reported in previous PD 
studies, with literature reporting mean values ranging from 392m (Falvo and Earhart, 
2009) to 546m (Canning et al, 2006). This variation in scores may be accounted for 
by factors such as age, disease severity and habitual physical activity. The study 
sample was older than in the above studies and included H&Y Stages I-IV; which 
may have contributed to the lower baseline 6MWT values. In a PD systematic review 
and meta-analysis of 39 trials of 1827 participants carried out by Tomlinson et al 
(2012), results demonstrated a mean increase in the distance walked in the 6MWT of 
13.37m following physiotherapy compared with no intervention. The authors 
highlighted the issue of a lack of MCID value published for the 6MWT for this 
patient cohort. However, they stated that a 13m increase in distance walked would 
probably be considered clinically important for PwPD. Taking this probability into 
66 
 
consideration, the results obtained in this study exceeded three times this value 
(37.67m). 
Steffen and Seney (2008) obtained a minimal detectable change (MDC) value of 
82m in a sample of 37 community-dwelling older adults with Parkinsonism. The 
MDC value of 82m was larger than desired due to a large SD resulting from a wide 
range of disease severities of the participants on the H&Y Scale. In their study, 
people with all types of Parkinsonism were included whereas, the inclusion criteria in 
this current research study only accepted people with idiopathic PD. This may have 
accounted for the variation in MDC values between the two studies. 
The optimal frequency and intensity of interventions in physiotherapy studies is a 
source of great debate in the PD literature (Redecker et al, 2014; European 
Guidelines 2014). Disparities are evident throughout the literature regarding optimal 
dosage. Ebersbach et al (2014), in an RCT compared the effects of the LSVT BIG 
standard protocol (16 individual sessions) with an amplitude-oriented training -
shorter protocol (AOT-SP) comprising 10 sessions in 42 PwPD where the secondary 
outcome of interest was the 6MWT. Participants had a H&Y score of 1-3 and were 
less severely affected than the population in this study. The difference of 58m was 
statistically significant (p<0.01) for the LSVT BIG group, however a differnce of 
30m was not statistically significant (p=0.08) for the AOT-SP group. The reduced 
training intensity of AOT-SP may not have been sufficient enough to obtain 
statistically significant improvements on the 6MWT. However, the authors 
recognised that a key limitation of the study was the potential attention bias in the 
LSVT BIG group. In this study, the time frame of six weeks for a class intervention 
reflects a pragmatic approach to exercise delivery in the context of current clinical 
practice within an acute hospital setting. Despite a lower training intensity of six 
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sessions in this research, participants managed to achieve a statistically significant 
improvement (p<0.01). The addition of an intensive daily HEP and the provision of 
novel exercise resources may have proven influential in achieving these results.  
As there is scant evidence pertaining to the effects of large-amplitude training on 
exercise tolerance, other modes of exercise interventions were evaluated from other 
exercise literature. In a systematic review and meta-analysis of 18 RCTs with 901 
participants, Hai-Feng et al (2014) suggested that aerobic exercise showed significant 
effects compared with control therapies of home exercise programmes in the 6MWT 
(95% CI=0.08, 1.36, p=0.03). In contrast, Canning et al (2013) in a pilot RCT 
investigated the feasibility and effectiveness of six weeks of home-based treadmill 
training in 20 people with mild PD, where the primary outcome measure of efficacy 
of walking capacity was the 6MWT. Results indicated that treadmill training did not 
improve walking capacity compared to the control walking group (p>0.05). These 
results may have been influenced by a small sample size and high drop rate (26%). 
Shulman et al (2013) compared three types of physical exercise in an RCT: (1) A 
higher-intensity treadmill exercise (30 minutes at 70%-80% of heart rate reserve), (2) 
a lower-intensity treadmill exercise (50 minutes at 40%-50% of heart rate reserve), 
and (3) stretching and resistance exercises (2 sets of 10 repetitions on each leg on 3 
resistance machines). These exercises were performed three times a week for three 
months. The primary outcome measure was the 6MWT. Results revealed that all 
three types of physical exercise resulted in improvements in the 6MWT: lower-
intensity treadmill exercise (12% increase; p=.001), stretching and resistance 
exercises (9% increase; p < .02), and higher-intensity treadmill exercise (6% 
increase; p = .07), with no between-group differences. Tai Chi is gaining increased 
attention in the PD literature not only for its significant impact on balance outcomes 
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(Li et al, 2012), but also for its effect on enhancing gait outcomes. In an RCT by 
Hackney et al (2008) 33 people with PD were randomly assigned to either a Tai Chi 
group or a control group. The Tai Chi group participated in 20 one-hour long training 
sessions completed within 10–13 weeks; whereas, the control group had two testing 
sessions between 10 and 13 weeks apart without interposed training. The Tai Chi 
group improved more than the control group on the 6MWT, Berg Balance Scale, 
UPDRS and TUAG. This was the first study to examine 6MWT performance before 
and after Tai Chi. The improvement noted (p=0.04) in the Tai Chi group may reflect 
improved balance (Li et al, 2012). Alternatively, the improvement may reflect 
increased endurance, as Tai Chi has been shown to reduce systolic blood pressure, 
total cholesterol, heart rate and low-density lipoprotein cholesterol levels after as 
little as 10 weeks
  
in Hong Kong Chinese women (Ko et al, 2006). 
 
4.1.3. Disease Severity Scale 
Two sub-categories of the MDS-UPDRS were used to establish the effect of large-
amplitude group exercise training on disease severity in the study sample. Part two 
measures self-reported motor experiences of daily living and part three measures the 
motor examination. 
Goetz et al (2008), described normative data in 80 PwPD, whereby part two 
demonstrated a mean score of 16.0 (SD 10), and section three had a mean score of 
36.8 (SD 18.4). In the current study, the mean score at baseline for the sample was 
10.70 (SD 4.84) for section two and 23.44 (SD 14.13) for section three indicating 
milder symptoms for this study sample. 
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No statistically significant improvement was demonstrated in self-reported motor 
experiences of daily living (p=0.583) between pre and post intervention. In contrast, 
there was a statistically significant improvement in the motor examination post 
intervention (p=0.04).                                                                                                                                                               
No MDC, MCID or cut-off scores have been established for the MDS-UPDRS. 
However, there is disparity in the literature around possible MCID values. In a RCT 
carried out by Schrag et al (2006), the authors concluded that the minimally 
important difference was between two and three points for part two and five points 
for the motor score. In a cross-sectional study, Shulman et al (2010), found that a six 
point improvement on the MDS-UPDRS motor section suggested to indicate a 
moderate, clinically important change in motor-symptom severity based on the 
UPDRS. The high correlation between the motor section of the UPDRS and the 
MDS-UPDRS (Goetz et al, 2008) suggests they can be directly compared as done in 
a recent Cochrane review of 39 trials (Tomlinson et al, 2012). Taking the above 
recommendations into account, the mean improvement of 3.72 observed in this study 
is approaching these desired minimally important differences. The smaller mean 
differences may be attributed to the difference in homogeneity of the sample group in 
this study and the shorter intervention period. 
The improvements made on the motor section of the UPDRS in the above studies are 
very similar to increased scores achieved by carrying out LSVT BIG training 
(Ebersbach et al, 2010). In this RCT, 60 patients with mild to moderate PD were 
randomly assigned to receive either LSVT BIG training (16 hours), group training of 
Nordic Walking (16 hours) or domestic non-supervised exercises. The primary 
efficacy measure was difference in change in the UPDRS motor score from baseline 
to follow-up at 16 weeks between groups. Results showed significant group 
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differences for UPDRS-motor score at final assessment (p<0.001). Mean 
improvement of UPDRS in the LSVT BIG group was -5.05 points (SD 3.91), 
whereas there was a mild deterioration of 0.58 (SD 3.17) in the Nordic Walking 
group and of 1.68 (SD 5.95) in the home group. This study sample demonstrated 
1.33 points lower in comparison to this RCT. This difference may be attributed to the 
fact that disease severity was lower in this RCT and also a longer intervention period 
was conducted in the LSVT BIG study. 
 
4.1.4. Functional Mobility 
Functional mobility, as measured by the TUAG, was found to improve to a 
statistically significant degree (p=0.01). A median improvement of 1.36 seconds was 
noted following the large-amplitude group training, representing a decrease in the 
length of time taken to complete the task.  
Huang et al (2011), derived an MDC value of 3.5 seconds for the TUAG from a 
convenience sample of 72 PwPD from a movement disorder clinic and the mean age 
of 67.5 years. This was not achieved in this study sample. Considering that the 
median score at baseline was 8.99 seconds, it would have been very difficult for 
participants’ to reduce their individual scores by one third in such a short timeframe. 
There are no floor/ceiling effects reported for PwPD, however, Rockwood et al 
(2000), have reported poor floor effects (29.3%) in elderly adults using the TUAG. 
The 1.36 second improvement is greater than the mean score of 0.63 second 
improvement conferred with other physiotherapy treatments reported in the Cochrane 
review (Tomlinson et al, 2012).  
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Results in this study are also greater than those reported by Ebersbach et al (2010), 
who saw statistically significant improvements (p=0.03) with a 0.75 second mean 
improvement in TUAG score having completed LSVT BIG intervention. 
In contrast to these results, some physiotherapy interventions (Steffen and Seney, 
2008) demonstrated significantly larger improvements (-4.5 seconds) than occurred 
in this study sample while others show no improvement at all. Nieuwboer et al 
(2007) conducted a randomised crossover trial of Rehabilitation in Parkinson’s 
disease: Strategies for Cueing (RESCUE) Trail with 153 participants, mean age 63.5 
years with a H&Y stage of 2-4. Participants received 12 weeks of cueing training in 
their home environment and statistically significant results were seen in various 
impairment outcomes. However no significant change was demonstrated for the 
TUAG (p>0.6). 
The cut-off score indicating risk of falls >11.5 seconds has been established for the 
TUAG in this patient population (Nocera et al, 2013). Results from this study 
indicated that two participants (11.11%) were a falls risk at baseline. Even though 
both these participants improved their TUAG over the six week intervention (median 
difference 1.81 seconds) they remained above the cut-off score.  
 
4.1.5. Balance 
The six week large-amplitude group exercise training also appeared to improve 
dynamic balance, measured using the DGI, which is also a key factor for falls risk. A 
median improvement of 2.5 points (p=0.01) was achieved between baseline and post 
intervention assessment.  
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Cakit et al (2007) derived normative baseline data for the DGI of 16.3 in a 
population of 31 PwPD with a H&Y stage 2-3. In this study, the median baseline 
DGI score obtained was 20 of a maximum 24. This may reflect the difference in 
population that are referred into the outpatient neurology physiotherapy service in 
comparison to those attending a rehabilitation unit. Also, the majority of participants 
in this study fell under a H&Y score of 1-2 indicating reduced severity of PD 
symptoms. 
Dibble et al (2008) derived a cut-off score of <19 as a discriminative indicator for 
falls risk. In contrast to the results observed for the TUAG where two participants 
were a falls risk both pre and post intervention, eight participants (44.44%) had a 
score <19 points for baseline DGI assessment and only 2 participants (11.11%) had 
scores <19 post intervention. This indicates that one third of participants 
demonstrated a falls risk prior to participating in the six week programme to 
demonstrating minimal risk of falls post intervention. This may be likely attributed to 
the fact that the large-amplitude group exercise programme incorporated progressive 
dynamic balance exercises of large-amplitude stepping, twisting, rocking and turning 
which mimics challenging balance tasks for PwPD in their everyday lives. 
Huang et al (2011) have derived an MDC value of 2.9 points for the DGI for PwPD. 
This study was very close to achieving this at 2.5 points.  
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4.1.6. Health-Related Quality of Life 
This six week large-amplitude group exercise training programme did not have a 
significant positive influence on HRQOL as measured by the PDQ-39. In fact, there 
was no trend towards improvement on any subsection of the PDQ-39. The difference 
in the mean change in the PD Summary Index (PDSI) score was also non-significant 
(p=0.56). Physical function has been shown to be predictive of QOL which suggests 
that enhancing mobility will improve QOL in PwPD (Ellis et al, 2011). Considering 
that statistically significant scores were achieved for both balance and gait outcomes 
in this study (6MWT, TUAG, DGI, MDS-UPDRS 3), it could be assumed that this 
would translate positively in a self-reported questionnaire. In addition to this, 100% 
of participants either agreed or strongly agreed that they found the large-amplitude 
training beneficial and would recommend the exercise programme to others. 
However, it has been acknowledged that a significant feature of answering the PDQ-
39 relies on the accuracy of recall in the last month. It is difficult to determine 
whether study participants limited their answers purely to the previous month when 
completing the questionnaire (Jenkinson et al, 1997). The results obtained may not 
be a true reflection of the effect of the intervention on QOL in this study sample.  
Despite this, results in this study are consistent with findings reported in the 
literature. In a Cochrane review of 39 trials, Tomlinson et al (2012) found no 
difference between treatment and control groups for mobility or the PDSI (p=0.73).  
Ebersbach et al (2010) found non-significant changes in the PDQ-39 following 16 
sessions of LSVT BIG or Nordic walking. The authors suggested that their small 
sample size of 60 participants may have been under-powered to detect moderate 
improvements in QOL.  
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4.2 Strengths of the Study 
 This feasibility study included relevant and recommended feasibility 
measures which are often under-reported in the literature. 
 This novel group exercise programme addressed a gap in the evidence 
regarding large-amplitude exercise for PwPD. 
 Validated primary and secondary outcome measures for PwPD were used to 
determine effectiveness across the International Classification of Functioning 
(ICF) of impairment, activity limitations and participation.  
 Assessor bias was minimised utilising a blinded assessor who had no 
affiliation to the study. 
 The study sample is representative of an outpatient PD service in an acute 
Regional teaching hospital. 
 
4.3 Study Limitations 
 Study Design: A pretest-posttest study design is less rigorous in comparison 
to the gold standard RCT or quasi-experimental design.  
 Sample Size: The study was under-powered due to a limited number of 
PwPD on the outpatient Neurology Database in NGH. Of this, a substantial 
number refused to participate for various reasons or failed to meet the 
eligibility criteria. 
 Resources: Service demands restricted colleagues in assisting with outcome 
measure assessment and class delivery. 
 Study Duration: The study was of short duration of six weeks in comparison 
to more intensive programmes of 10 weeks recommended in the literature. 
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 Inadequate follow-up: The blinded outcome assessor was not available to 
complete follow-up assessments. 
 Exercise Tolerance: Aerobic intensity was not measured for the 6MWT 
 
4.5 Areas for Future Research 
Due to the lack of research pertaining specifically to large-amplitude training in the 
treatment of PD, the author recommends that future research could be conducted that 
incorporates: 
 A larger sample size to ensure that the study is adequately powered to infer 
statistically significant results. 
 A more rigorous study design such as an RCT of large-amplitude group 
exercise training compared to usual physiotherapy care, incorporating an 
intervention phase greater than six weeks and an adequate follow-up period 
of one year to determine the maintenance of gains achieved. 
 High quality studies investigating exercise-induced changes in the brain and 
their associated functional outcomes. 
 Qualitative research methods such as semi-structured interviews to gain a 
deeper insight into the barriers, facilitators and motivators of exercise from 
the participant’s perspective. This knowledge will influence the structure of 
future exercise programmes and facilitate with exercise compliance over the 
longer term in this population. 
 
 
76 
 
CONCLUSION 
A six week large-amplitude group exercise training programme for individuals with 
mild-moderate PD was feasible and safe to carry out in both a hospital setting and a 
home environment. Attendance rates and retention rates were very satisfactory. The 
provision of relevant exercise resources such as an exercise logbook, exercise photo 
pack, exercise DVD and a YouTube exercise link appeared to facilitate with 
increased compliance and satisfaction with the class. The majority of participants 
found the class very beneficial and preferred it to one-to-one intervention. The large-
amplitude group exercise class also demonstrated statistically significant positive 
effects on functional physical performance outcomes of exercise endurance 
(6MWT), dynamic balance (DGI), functional mobility (TUAG)  and PD-related 
motor severity in the study sample (MDS-UPDRS Part III). However, non-
significant changes were noted for PD-related ADLs (MDS-UPDRS Part II) and 
HRQOL (PDQ-39). However, these results must be interpreted with caution as the 
primary and secondary clinical outcome measures were not powered to detect 
changes in these outcomes. 
 
The study sample were recruited from the physiotherapy PD outpatient database in 
Naas General Hospital. Inclusion criteria deemed that participants needed to be 
independently mobile with or without a walking aid. The mean average H&Y for this 
study sample was 1.72 indicating a low disease disability. The duration and intensity 
of the intervention reflects current clinical practice in Ireland, but may not be 
sufficient to achieve sufficient changes in functional physical performance outcomes. 
Other studies have demonstrated more favourable outcomes with increased 
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frequency and duration of interventions. However, these interventions required 1:1 
intervention and are not cost or resource effective in an Irish setting.  
 
In conclusion, individuals with mild-moderate PD may benefit from regular 
participation in large-amplitude group exercise training as it may possibly improve 
exercise tolerance, functional mobility and dynamic balance. Further research is 
required to determine the efficacy of this intervention with a more rigorous study 
design, larger sample size and adequate follow-up of 1 year post intervention.  
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Appendix 4: Hoehn and Yahr Clinical Rating Scale for Parkinson’s Disease 
 
Hoehn and Yahr Scale  
1 
 
 
2 
 
 
3 
 
4 
  
                                           
5 
Only Unilateral involvement, usually with minimal or 
no functional disability 
 
Bilateral or midline involvement without impairment of  
balance 
 
Bilateral disease: mild to moderate disability with 
impaired postural reflexes; physically independent 
 
Severely disabling disease; still able to walk or stand 
unassisted 
 
Confinement to bed or wheelchair unless aided 
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Appendix 5: Ethical Approval Letter Naas General Hospital 
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Appendix 6: Ethics Form 
Version 5.5 May 2011 
STANDARD APPLICATION 
FORM 
 
For the Ethical Review of 
Health-Related Research Studies, 
which are not Clinical Trials of 
Medicinal Products For Human Use  
as defined in S.I. 190/2004 
 
DO NOT COMPLETE THIS APPLICATION FORM 
 IF YOUR STUDY IS A CLINICAL TRIAL OF A MEDICINAL PRODUCT 
Title of Study:  
Large-Amplitude Group Exercise Training for Individuals with 
Parkinson’s Disease: A Pilot Intervention Study 
 
Principal Investigator:  
Eimear Manley 
 
 
 
For Official Use Only – Date Stamp of Receipt by REC: 
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3 TABLE OF CONTENTS MANDATORY 
/OPTIONAL 
 
SECTION A GENERAL INFORMATION MANDATORY 
 
SECTION B STUDY DESCRIPTORS MANDATORY 
 
SECTION C STUDY PARTICIPANTS MANDATORY 
 
SECTION D RESEARCH PROCEDURES MANDATORY 
 
SECTION E DATA PROTECTION MANDATORY 
 
SECTION F HUMAN BIOLOGICAL MATERIAL OPTIONAL 
 
SECTION G RADIOCATIVE MATERIAL / DIAGNOSTIC OR  
THERAPEUTIC IONISING RADIATION OPTIONAL 
 
SECTION H MEDICAL DEVICES OPTIONAL 
 
SECTION I MEDICINAL PRODUCTS / COSMETICS / FOOD AND FOODSTUFFS OPTIONAL 
 
SECTION J INDEMNITY MANDATORY 
 
SECTION K COST AND RESOURCE IMPLICATIONS AND FUNDING MANDATORY 
 
SECTION I ETHICAL ISSUES MANDATORY 
 
 
This Application Form is divided into Sections. 
 
Sections A, B, C, D, E, J, K, L are Mandatory. 
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Sections F, G, H, and I are optional.  Please delete Sections F, G, H, and I 
if these sections do not apply to the application being submitted for 
review. 
 
IMPORTANT NOTE:  Please refer to Section I within the form before 
any attempt to complete the Standard Application Form.  Section I is 
designed to assist applicants in ascertaining if their research study is in 
fact a clinical trial of a medicinal product. 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
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4 SECTION A  GENERAL INFORMATION  
 
SECTION A IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
A1 Title of the Research Study: 
   
Large-Amplitude Group Exercise Training for Individuals with Parkinson’s 
Disease: A Pilot Intervention Study 
 
A2  Principal Investigator(s):   
Title:  Ms. Name:  Eimear Manley  
Qualifications: BSc (Hons) Physiotherapy   
Position:  Staff Grade Physiotherapist 
Dept:       Physiotherapy 
Organisation:  Naas General Hospital 
Address: Naas, Co Kildare 
Tel:  045-849941 E-mail: Eimear.manley@hse.ie 
 
A3 (a) Is this a multi-site study?    No   
 
A3 (b) Please name each site where this study is proposed to take 
place and state the lead investigator for each site: 
 
Site: Lead Investigator: 
PHYSIOTHERAPY DEPARTMENT, 
NAAS GENERAL HOSPITAL, 
NAAS, 
CO. KILDARE 
EIMEAR MANLEY 
 
A3 (c) For any of the sites listed above, have you got an 
outcome from the research ethics committee (where 
applicable)? 
  
No 
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A4.  Co-Investigators: 
 
Name of site     
 
Royal College of Surgeons 
 
Title: Dr.  Name:  HELEN FRENCH 
Qualifications:  PhD, MSc, B.Physio, Dip Stat  
Position:  Lecturer in Physiotherapy  
Organisation:  Royal College of Surgeons 
Address:School of Physiotherapy, 123 St Stephens Green, Dublin 2 
Role in Research:  Supervisor 
 
A4.  Co-Investigators: 
 
Name of site     
Naas General Hospital 
 
Title: Dr.  Name:  MARY MARTIN 
Position:  Consultant Geriatrician  
Organisation:  Naas General Hospital 
Address:Naas, Co Kildare 
Role in Research:  Co-Investigator 
 
 
A5.  Lead contact person who is to receive correspondence in 
relation to this application or be contacted with queries about 
this application.  
 
Title: Ms. Name:   Eimear Manley 
Address:  Physiotherapy Department, Naas General Hospital 
Tel (work):  045-849941 Tel (mob.):  
 087-1257242 
E-mail: Eimear.manley@hse.ie  
 
A6.   Please provide a lay description of the study.  
The aim of the study is to assess the feasibility and efficacy of a six week 
group exercise programme on physical performance outcomes in 
individuals with mild-moderate Parkinson’s Disease (PD). Gait and 
balance disturbance is extremely common in PD and is a major 
contributor to increased disability and decreased health-related quality of 
life. Therefore, treatment strategies such as exercise to treat mobility 
and balance impairments in PD are paramount. Various exercise 
strategies have been developed to target these deficits. One such 
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rehabilitation approach which has shown to be effective is Lee Silverman 
Voice Training (LSVT) BIG. This is a unique approach in the fact that it 
targets (BIG) movement amplitude as a single treatment parameter. 
However, this rehabilitation approach is standardised, consisting of 4 1-
hourly individualised treatment sessions, 4 times a week. This intensity of 
training is not feasible in an acute hospital setting. The researcher 
proposes to incorporate principles of LSVT BIG/large amplitude training 
into a group setting to assess its feasibility and potential efficacy.  
 
A7 (a) Is this study being undertaken as part of an academic 
qualification? Yes   
 
A7 (b) If yes, please complete the following: 
Student Name:  Eimear Manley  
Course:  MSc Physiotherapy (Neurology and Gerontology) 
Institution:  Royal College of Surgeons of Ireland 
Academic Supervisor: Dr. Helen French 
 
 
 
 
5 SECTION B STUDY DESCRIPTORS 
 
SECTION B IS MANDATORY 
 
B1.   Provide information on the study background.  
Parkinson’s Disease (PD) is a complex, chronic and progressive 
neurodegenerative disorder. It consists of a constellation of motor and 
nonmotor symptoms affecting the physical, psychological, social and 
functional status of individuals (Goodwin et al, 2008). In the course of 
the disease, most people with PD face mounting mobility deficits 
including difficulties with transfers, posture, balance and walking, which 
leads to a loss of independence, injury, inactivity resulting in social 
isolation and increased risk of osteoporosis and cardiovascular disease 
(Keus et al, 2007). There are approximately 9,000 people in Ireland 
living with PD (Parkinsons.ie). 
 
Pharmacological therapy is the primary treatment modality for PD and 
serves to slow the onset of disease progression and limit the clinical 
manifestations of the condition (Katzenschlager et al, 2008). 
Unfortunately, current pharmacologic and surgical treatment options for 
gait and balance disturbances are limited (Vu TC et al, 2012). Therefore, 
there is a pressing need for other (nonpharmacolgic) treatment strategies 
such as exercise to treat mobility impairments in PD.  
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Several comprehensive meta-analyses and Cochrane reviews  (Keus et 
al, 2006; Goodwin et al, 2008; Tomlinson et al, 2012) have been 
published on this topic over the last few years. A great advancement in 
recent literature for PD has been the publication of the 2015 European 
Physiotherapy Guidelines for PD.  
 
Exercise has become an established and beneficial therapeutic adjunct in 
the management of PD. Numerous types of exercise models and 
strategies have been advocated for people with PD targeting mobility and 
balance impairments such as: Progressive resistance training (Falvo et al, 
2008; Sage et al, 2011), treadmill training (Herman et al, 2008), various 
forms of dance (Duncan and Earhart, 2010), Tai Chi (Li F et al, 2012), 
boxing (Combs et al, 2011) sensoriagility training (King and Horak, 
2008). Various models of rehabilitation often use compensatory 
strategies to bypass the basal ganglia as the basis of their therapeutic 
management (Nieuwboer et al, 2008). In contrast, there is a growing 
body of evidence favouring a neuroplasticity-principled rehabilitation 
model (Farley et al, 2008). 
 
One particular exercise model that incorporates the latter restorative 
approach is Lee Silverman Voice Therapy (LSVT BIG). Developed in 2005 
(Farley et al, 2005), LSVT BIG is an intensive high-amplitude 
standardised exercise protocol. The recent European guidelines have 
recommended this exercise approach for training balance and mobility 
impairments. 
This standardised exercise protocol was piloted with one individual in 
January 2014 in Naas General Hospital which produced excellent results. 
A Case Study of this pilot intervention programme was published in the 
Irish Society of Chartered Physiotherapists (ISCP) Firsthand Magazine 
highlighting its efficacy. However, the authors highlighted numerous 
limitations with this protocol regarding time, staff time, staff resources 
and feasibility issues for the participant to commit to such high doses of 
intensity of training. 
To overcome these barriers, the researcher proposes to adopt principles 
from LSVT BIG training incorporating elements of motor learning 
principles in the form of a six week (once weekly) group-based exercise 
programme for people with mild-moderate PD.   
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B2.    List the study aims and objectives.   
 
Aims: 
To assess the feasibility and efficacy of a six week large-amplitude group 
exercise class on physical performance in individuals with PD. 
 
Objectives: 
To determine if a one hour-weekly large-amplitude group exercise plus 
independent daily intensive home exercise programme is: 
1 Feasible and Safe? 
2 Improves physical performance measures in mild-moderate PD 
3 Improves health related quality of life 
3 Yields patient satisfaction and facilitates with exercise compliance 
 
B3.    List the study endpoints (if applicable).  
 
The primary outcomes are to evaluate the feasibility and efficacy of a 
large-amplitude group exercise class on physical performance measures 
with mild-moderate PD 
 
B4.   Provide information on the study design. 
 
Pretest-Posttest Pilot Experimental Design 
 
B5.   Provide information on the study methodology. 
  
Study Design: 
A pretest-posttest pilot intervention design of one patient group will be 
conducted to ascertain the feasibility and efficacy of a large-amplitude 
group exercise class on individual with mild-moderate PD living in 
Kildare/West Wicklow. This study design type was deemed most 
appropriate by the investigator to address the research question and 
primary outcomes of feasibility and clinical efficacy. All eligible and willing 
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participants will receive the intervention. People with moderate-severe 
PD are excluded from the programme but this will not affect their routine 
care and treatment offered from the outpatient neurology service. 
 
Subject Recruitment: 
The participants will be recruited from the outpatient neurology waiting 
list and PD review database. Patients from the database may have 
attended for physiotherapy intervention and a PD class in the past. 
However, participants will be excluded if they have attended for 
physiotherapy in the previous 3 months – which allows for a washout 
period of treatment effect. If recruitment is posing difficult, potential Day 
Hospital clients may be invited to participate in the study. This will not 
affect their routine care in Day Hospital. 
 
The participants will be sent an invitation letter (Appendix 1) from the 
Deputy Physiotherapy Manager who will act as gatekeeper for the trial 
inviting them to participate in the research programme. The invitation 
letter will be accompanied by a patient information leaflet (Appendix 2) 
and consent form (Appendix 3) which will outline the purpose and nature 
of the study. The participants will have at least seven days to digest this 
information and decide whether they wish to partake in the research 
study or not. Participants will then be contacted by the principal 
investigator to ensure eligibility and baseline assessments will be 
scheduled at this time. Verbal consent will be made over the phone with 
written consent provided at the baseline assessments.  
To minimise the possibility of assessor bias and reduce threats to 
instrumentation internal validity, a blinded assessor will carry out 
baseline and post intervention assessments (UCD undergraduate student 
on clinical placement. This student will be under the direction and 
supervision of a Senior Clinical Tutor). The researcher will ensure that 
optimal training will be provided to the Undergraduate student prior to 
outcome assessment to minimise the threats of novice error. 
Due to staffing resources in the physiotherapy department, the 
physiotherapy manager could not justify the time for the neurology 
service to carry out the quantity of assessments, therefore, this is 
another reason why this blind assessor has been selected. 
Assessments will take place in the physiotherapy gym. It will take 
approximately 30-35minutes to complete assessments. 
 
 
 
94 
 
 
Inclusion Criteria: 
1. Diagnosis of Ideopathic Parkinson’s Disease diagnosed by a Consultant 
Neurologist 
2. Hoehn and Yahr Scale 1-3 (Appendix 4) 
3. Independent Mobile 
4. Ability to give informed consent and follow simple commands 
 
Exclusion Criteria: 
1 Non-Ideopathic PD 
2. Unstable Cardiovascular Disease 
3. Uncontrolled Chronic Condition 
4. Confirmed Diagnosis of Dementia/PD Related Dementia 
5. Received Physiotherapy for PD in the last 3 months 
 
Intervention: 
The large-amplitude exercises classes will take place in the front 
physiotherapy gym. The treatment intervention shall consist of a 5 
minute warm up, followed by large amplitude stretches and movement 
sequences (x15minutes), large-amplitude task specific exercises 
(x30mins) and a cool down of 5 minutes. A progression of the exercises 
will be three times over the course of the six week programme. 
A maximum of 6 participants will partake in each class. 
If successful recruitment of the target sample size of 24 is achieved, this 
correlates to 4 exercises classes per week over a 6 week period. 
Likewise, if a reduced number is recruited (eg 18 participants) 3 exercise 
classes will take place. 
The PI has discussed the justification and the feasibility of time and 
resources with the physiotherapy manager for conducting the 
intervention. 
Safety procedures will be adhered to with all staff involved having CPR 
certification and access to the cardiac arrest trolley located in the nearby 
endoscopy department.  
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Outcome Measures:  
 
Feasibility Outcomes: 
For the purpose of this study, feasibility is adopted as an umbrella term, 
encompassing the constructs of safety, exercise compliance, adherence 
rates, retention rates and participant satisfaction with the exercise 
programme. 
Safety during the intervention phase will be monitored by structured 
weekly screening by the intervention therapist for any new soreness 
lasting longer than 48 hours related to therapy and by recording of any 
adverse events (injury, near-miss accident, fall) both during the 
intervention and carrying out the intensive home exercise programme 
(Appendices 6 and 7).  
Exercise compliance will be monitored by weekly review of a completed 
home exercise logbook (Appendix 8). 
Adherence will be evaluated using weekly attendance records at the 
intervention session (Appendix 9). 
Retention rates will be evaluated by comparing the proportion of 
participant who attend for baseline assessment V the proportion who 
attend for post intervention assessment. 
Participant Satisfaction with the programme will be evaluated using a 
non-validated Questionnaire (Appendix 10). 
 
Primary Outcome Measure: 
Six minute walk test: Individuals walk up and down a 10m walkway for 
six minutes, as quickly as the subject can as long as they feel safe and 
comfortable. They may have as many seated rests as required over the 
course of the six minutes (American Thoracic Society, 2002)(Appendix 
11) 
 
Secondary Outcome Measures: 
Timed Up and Go Test: this test requires the individual to stand up from 
a chair, walk a 3 metre distance, turn around, return and sit down again. 
The functional mobility performance is timed (Podsialdo and Richardson, 
1991)(Appendix 12) 
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Dynamic Gait Index: this is a test of dynamic balance when there are 
threats to external demands. It is recommended as the best evaluating 
tool for measuring balance in PD (European Guidelines, 2015) (Appendix 
13) 
MDS-UPDRS: An impairment measurement of disease severity. 
 Motor ADL (Section II) and Motor Examination (Section III) will be 
evaluated (Goetz et al, 2008) (Appendix 14)  
 
PDQ-39: This is a disease specific measure of quality of life (Peto et al, 
1995) and has been shown to be sensitive to changes that matter to the 
individuals. 
 
B6.   What is the anticipated start date of this study? 
  
Early September 
 
B7.   What is the anticipated duration of this study? 
  
September 2015 – April 2016: (8 months) 
 
 
B8 (a) How many research participants are to be recruited in 
total? 
  
24 
 
B8 (b)   Provide information on the statistical approach to be used 
(if appropriate) / source of any statistical advice.   
 
Descriptive statistics will be used to describe baseline demographic 
information (Appendix 5) and feasibility measures. 
To determine if there is a significant difference in clinical scores from 
pretest to posttest intervention a paired t-test will be used to assess 
parametric results and a Wilcoxon signed-rank test will be used to 
evaluate non-parametric tests. 
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B8 (c)  Please justify the proposed sample size and provide 
details of its calculation (including minimum clinically important 
difference).   
As there is no Minimum Clinically Important Difference (MCID) for the 
primary outcome measure of the Six minute walk test for PD the 
researcher is adopting a sample size power calculation from a previous 
similar study using this primary outcome measure in this cohort of 
participants. A sample size of 24 was sought to show an increase of 
82metres on the Six Minute Walk Test (MDC) with an alpha of 5% and a 
power of 80% 
 
B8 (d)  Where sample size calculation is impossible (e.g. It is a 
pilot study and previous studies cannot be used to provide the 
required estimates) then please explain why the sample size to 
be used has been chosen.   
 
See Above 
 
 
 
6 SECTION C study PARTICIPANTS 
 
SECTION C IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
7 SECTION C1 PARTICIPANTS – SELECTION AND RECRUITMENT 
 
 
C1. 1 How many research participants are to be recruited?  At 
each site (if applicable)? And in each treatment group of the 
study (if applicable)?   
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Name of site: Names of Treatment Group (if 
applicable) 
Insert name 
of group:  
Insert 
name of 
group:  
Insert name 
of group:  
Physiotherapy 
Department, Naas 
General Hospital, Naas, 
Co. Kildare 
LARGE-
AMPLITUDE 
GROUP 
EXERCISE 
TRAINING 
  
    
 
C1.2  How will the participants in the study be selected?  
 
The participants will be recruited form the physiotherapy department out-
patient neurology waiting list and physiotherapy review PD database. If 
recruitment is posing difficult, potential PD participants from the Day 
Hospital may be invited to partake in the study. 
 
 
C1.3  How will the participants in the study be recruited?   
 
The participants will be sent an invitation letter (Appendix 1) from the 
Deputy Physiotherapy Manager who will act as gatekeeper for the trial 
inviting them to participate in the research programme. The invitation 
letter will be accompanied by a patient information leaflet (Appendix 2) 
and consent form (Appendix 3) which will outline the purpose and nature 
of the study. The participants will have considerable amount of time to 
digest this information and consider if they wish to volunteer for the 
study or not. Participants will then be contacted by the principal 
investigator to ensure eligibility and baseline assessments will be 
scheduled at this time. Verbal consent will be gained over the phone with 
written consent provided at baseline assessments.  
 
C1.4 What are the main inclusion criteria for research 
participants?  (please justify)  
 
1. Diagnosis of Ideopathic Parkinson’s Disease diagnosed by a Consultant 
Neurologist 
2. Hoehn and Yahr Scale 1-3 as any stage greater than this will require a 
lot of supervision (Appendix 4) 
3. Independent Mobile with or without a gait aid 
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4. Ability to give informed consent and follow simple commands 
C1.5 What are the main exclusion criteria for research 
participants?  (please justify) 
 
1 Non-Ideopathic PD 
2. Unstable Cardiovascular Disease 
3. Uncontrolled Chronic Condition 
4. Doctor confirmed Diagnosis of Dementia/PD Related Dementia – this 
was discussed with the co-investigator Dr. Mary Martin.  
5. Attended Physiotherapy intervention in the last 3 months – This 
timeframe is adopted in numerous PD published trials. 
 
C1.6 Will any participants recruited to this research study be 
simultaneously involved in any other research project?  
 No 
 
 
8 SECTION C2 PARTICIPANTS – INFORMED CONSENT 
 
 
C2.1 (a) Will informed consent be obtained?  Yes 
 
C2.1 (c) If yes, how will informed consent be obtained and by 
whom? 
 
Potential participants will receive an information pack containing a study 
invitation letter, patient information leaflet and consent form from the 
gatekeeper. Potential participants will be contacted after a cooling period 
of at least one week after they receive documentation to determine 
consent. Verbal consent will be acknowledged over the phone, however, 
written consent will be obtained at baseline assessment.  
 
C2.1 (d) Will participants be informed of their right to refuse to 
participate and their right to withdraw from this research 
study? 
 
Yes. It is stated clearly in the patient information leaflet that there is no 
obligation to participate in the study and that participants may withdraw 
at any time without affecting their care. 
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The investigator will also be guided by her professional code of conduct 
as stipulated by the ISCP. 
C2.1 (f) Will there be a time interval between giving 
information and seeking consent? Yes  
 
 
C2.1 (g) If yes, please elaborate. 
   
Participants will be given a cooling off period of at least 7 days to make a 
decision regarding participation into the research study. 
 
 
9 SECTION C3 adult participants - CAPACITY 
 
 
C3.1 (a) Will all adult research participants have the capacity 
to give informed consent?  Yes, as this is stipulated in the inclusion 
criteria  
 
C3.1 (b) If no, please elaborate 
 
C3.1 (c) If no, is this research of such a nature that it can only 
be carried out on adults without capacity?  No 
 
C3.1 (d) What arrangements are in place for research 
participants who may regain their capacity?   
 
Not Applicable 
 
 
10 SECTION c4 participants under the age of 18 
 
C4.1  (a) Will any research participants be under the age of 18 
i.e. Children?  
No 
 
 
11 SECTION C5 PARTICIPANTS -  CHECKLIST  
 
Please confirm if any of the following groups will participate in 
this study.  This is a quick checklist for research ethics committee 
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members and it is recognised that not all groups in this listing will 
automatically be vulnerable or lacking in capacity. 
 
C5.1 Patients  Yes  
C5.2 Unconscious patients  No 
C5.3 Current psychiatric in-patients No 
C5.4 Patients in an emergency medical setting No 
C5.5 Relatives / Carers of patients No 
C5.6 Healthy Volunteers No 
C5.7 Students No 
C5.8 Employees / staff members No 
C5.9 Prisoners No 
C5.10 Residents of nursing homes No   
C5.11 Pregnant women  No 
C5.12 Women of child bearing potential  No 
C5.13 Breastfeeding mothers No 
C5.14 Persons with an acquired brain injury  No 
C5.15 Intellectually impaired persons No 
C5.16 Persons aged > 65 years Yes  
 
C5.17 If yes to any of the above, what special arrangements 
have been made to deal with issues of consent and assent (if 
any)? 
   
Refer to C2.1 c  
 
 
12 SECTION D research  PROCEDURES 
 
SECTION D IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
D1.  What research procedures or interventions (over and 
above those clinically indicated and/or over and above those 
which are part of routine care) will research participants 
undergo whilst participating in this study? 
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Research participants will undergo a 6 week (once-weekly) large-
amplitude group exercise class in the physiotherapy department. 
The primary focus of the intervention is on feasibility and clinical efficacy 
outcomes regarding physical performance. 
D2.  If there are any potential harms resulting from any of the 
above listed procedures, provide details below: 
 
The participants will be participating in a group exercise class. Group 
exercises classes are a routine component of physiotherapy intervention. 
As with any group exercise class there is a small risk of falls or injury, 
however, the participants will be supervised at all times and an 
environmental risk assessment will be conducted as per usual care prior 
to each class. 
An adverse events form will be documented completed weekly (Appendix 
6) 
In the rare case of an incident, the investigator will adhere to hospital 
protocol regarding completion of an incident recording form and report 
any adverse events to members of the research ethics committee as 
outlined in the policy for undertaking research in Naas General Hospital. 
 
 
D3.  What is the potential benefit that may occur as a result of 
this study?  
 
Participation in the class may improve physical performance measures of 
enhance mobility, balance, confidence, quality of life. 
Social engagement and peer support 
 
D4 (a) Will the study involve the withholding of treatment? 
No  
 
D4 (b) Will there be any harms that could result from 
withholding treatment?  N/A 
 
D5.  How will the health of participants be monitored during 
and after the study? 
 
The participants will be monitored as part of usual care by the therapist 
taking the class. 
The validated outcome measures will be used to evaluate health 
improvements over the course of the 6 weeks. 
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Safety evaluation forms will be completed during the intervention and by 
the participants at home while carrying out their home exercise 
programme. 
 
D6 (a) Will the interventions provided during the study be 
available if needed after the termination of the study? Not 
Applicable as this is not a Randomised Controlled Trial  
 
D6 (b) If yes, please state the intervention you are referring to 
and state who will bear the cost of provision of this 
intervention? 
   
Not Applicable 
 
 
D7.  Please comment on how individual results will be 
managed.  
 
Results and outcomes of the study will be sent to the referring Dr and 
also to the participant’s Consultant Neurologist (Appendix 16) 
This is part of routine clinical practice 
 
D8.  Please comment on how aggregated study results will be 
made available. 
 
 Results will be submitted as part of a Masters thesis to RCSI. 
 Dissemination at key conferences and peer reviewed journals – if 
this occurs, Naas General Hospital will be acknowledged as a 
publication site for research 
 The results will also be submitted to the Physiotherapy Manager as 
part of a Quality Improvement Project. 
 Power Point Presentation will be provided to all Physiotherapy Staff 
at a General In-Service Training. 
 Power Point Presentation will be provided at the Hospitals Research 
and Education Forum. 
 
D9.  Will the research participant's general practitioner be 
informed the research participant is taking part in the study (if 
appropriate)?  If the GP is the referring Doctor then a  letter 
explaining that the participant is partaking in the study and a brief 
outline of the study will be issued 
 
D10.  Will the research participant's hospital consultant be 
informed the research participant is taking part in the study (if 
appropriate)? 
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 Non-applicable 
 
 
13 SECTION E Data Protection 
 
SECTION E IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
14 SECTION E1  data processing - consent 
 
E1.1 (a)  Will consent be sought for the processing of data? Yes  
 
 
SECTION E2 data processing - GENERAL 
 
 
E2.1  Who will have access to the data which is collected?  
 
The hard copy records of data will be stored in a locked filing cabinet in 
the physiotherapy department accessibly only to the principle investigator 
(PI) and physiotherapy manager. 
All electronic data will be coded and anonymous and stored on the PI 
password protected computer in the physiotherapy department. 
 
E2.2  What media of data will be collected? 
 
Computerised spreadsheets and hard copy paper forms 
 
E2.3 (a) Would you class the data collected in this study as 
anonymous, irrevocably anonymised, pseudonymised, coded or 
identifiable data? 
  
Coded and Anonymous  
 
E2.3 (b) If ‘coded’, please confirm who will retain the ‘key’ to 
re-identify the data? 
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The PI will retain the “key” which will remain in a locked filing cabinet in 
the  physiotherapy department – this will be kept separately from the 
original data, therefore, only the PI will be able to identify the data 
optimises confidentiality 
Electronic data will be stored on a password protected computer which is 
unique to the PI 
 
E2.4  Where will data which is collected be stored? 
   
Hard copy records will be stored in a locked filing cabinet in the 
physiotherapy department, where the PI and the Physiotherapy manager 
only will have access to . 
Electronic data will be stored on the principal investigator’s password 
protected computer in the physiotherapy department 
 
E2.5   Please comment on security measures which have been 
put in place to ensure the security of collected data. 
   
All of the above 
Also, the investigator has reviewed relevant hospital and HSE data 
protection policies to ensure full knowledge and awareness of adequate 
security measures: 
1 Data Protection and Freedom of Information Legislation – Guidance for 
Health Service Staff 
2. Data Protection – Its Everyones Responsibility; An Introductory guide 
for Health Service Staff 
 
E2.6 (a) Will data collected be at any stage leaving the site of 
origin?    
No 
 
 
E2.7   Where will data analysis take place and who will perform 
data analysis (if known)? 
  
In Naas General Hospital by the Principal Investigator  
This will be conducted out of work hours 
   
E2.8 (a) After data analysis has taken place, will data be 
destroyed or retained? 
 
106 
 
Retained for a period of 5 years in accordance with Data Protection 
Legislation, after which time it will be destroyed 
 
E2.8 (b) Please elaborate.  
 
Clinical data will be retained as part of participant healthcare records as 
per routine clinical practice. This is outlined in the Data Protection 
Records Retention Policy. 
Research data will be destroyed. 
 
E2.8 (c) If destroyed, how, when and by whom will it be 
destroyed? 
   
How: Shredding of Confidential Data using on site HSE shredding – this 
shredded paper can be recycled as part of a recyclables collection (Data 
Protection Policy) 
Whom: The PI 
 
E2.8 (d) If retained, for how long, for what purpose, and where 
will it be retained?   
 
Hard data in a locked filing cabinet in the physiotherapy department, 
electronic data on a password protected computer in the physiotherapy 
department for five years after the period of data collection. 
This timeframe is stipulated by the Royal College of Surgeons in Ireland 
with respect to good research practice when conducting a research study. 
 
E2.9   Please comment on the confidentiality of collected data. 
  
The following measures will be taken to ensure confidentiality of data: 
1 Participants will be provided with a unique identifier number. This will 
be kept in a separate file to the hard data of electronic data and will be 
stored separately 
2 names and other details that may identify the participants will be 
removed 
3 Only the investigator will have access to and be aware of the “key” to 
these codes 
4 All data collected will be saved in a password protected computer of the 
PI 
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5 This password is unique and has a minimum of 8 characters in length 
with a combination of letters and numbers to increase complexity (Data 
Protection Policy) 
5 All hard copies of written documentation will be secured in a locked 
filing cabinet 
6 Access to the study data will be restricted to the PI 
 
    
E2.10 (a) Will any of the interview data collected consist of 
audio recordings / video recordings? No 
 
 
E2.11 (a) Will any of the study data collected consist of 
photographs/ video recordings?  No 
 
 
 
15 SECTION e3 ACCESS TO HEALTHCARE RECORDS 
 
 
E3.1 (a) Does the study involve access to healthcare records 
(hard copy / electronic)?  No; information regarding indications for 
treatment, PMedHx and Meds should be provided by referring source. 
If this is not explicit, the principal investigator will contact the 
referring source for this information 
 
E3.1 (b) If yes, please elaborate.  
  
Not applicable 
 
E3.1 (c) Who will access these healthcare records? 
    
Not Applicable 
 
E3.1 (d) Will consent be sought from patients for research 
team members to access their healthcare records?  Yes / No 
 
E3.2 (a) Who or what legal entity is the data controller in 
respect of the healthcare records? 
   
Not applicable 
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E3.2 (b) What measures have been put in place by the data 
controller which may make access to healthcare records 
permissible without consent? 
   
Not applicable 
 
 
16 SECTION f HUMAN BIOLOGICAL MATERIAL 
 
 
17 f1 Bodily Tissue / Bodily Fluid Samples - general 
 
 
F1 1 (a) Does this study involve human biological material?  No 
 
If answer is No.  Please delete following questions in Section F. 
 
18 section G radioactive material / diagnostic or therapeutic ionising radiation 
 
 
19 G1 radioactive material / diagnostic or therapeutic ionising radiation 
- general 
 
 
G1.1  (a) Does this study/trial involve exposure to radioactive 
materials  or  does this study/trial involve other diagnostic or 
therapeutic ionising radiation?   No 
 
If the answer to question G1.1(a) is No,  please delete the following questions in this 
Section. 
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19.1  
19.2  
19.3  
19.4  
19.5  
19.6  
19.7                   
19.8 SECTION H  MEDICAL DEVICES 
 
 
 
H1 (a) Is the focus of this study/trial to investigate/evaluate a 
medical device?   No 
If the answer to question H1 (a) is No,  please delete the following questions in this 
Section. 
 
20  
21 SECTION I MEDICINAL PRODUCTS / COSMETICS / FOOD AND 
FOODSTUFFS 
 
Section I is designed to assist applicants in ascertaining if their research study is in 
fact a clinical trial of a medicinal product.  Section I is optional.  Please delete if this 
section does not apply. 
 
22 SECTION I.1 NON-INTERVENTIONAL TRIALS OF MEDICINAL 
PRODUCTS 
 
I1.1 (a)  Does this study involve a medicinal product? No 
 
If the answer to question I1.1 (a) is No,  please delete the following 
questions in this Section. 
 
 
23  
24 SECTION I.2 COSMETICS 
 
I2.1 (a)  Does this study involve a cosmetic?  No 
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If the answer to question I 2.1 (a) is No,  please delete the following 
questions in Sub-Section I 2. 
 
 
 
25 SECTION I.3 FOOD AND FOOD SUPPLEMENTS 
 
I3.1 (a) Does this study involve food or food supplements?  No 
 
If the answer to question I 3.1 (a) is No,  please delete the following 
question in Sub-Section I 3. 
 
 
 
25.1 SECTION j INDEMNITY 
 
SECTION J IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
J1 (a) Is each site in which this study is to take place covered 
by the Clinical Indemnity Scheme (CIS)?  Yes  
 
 
J2 (a) Is each member of the investigative team covered by the 
Clinical Indemnity Scheme (CIS)?  Yes. The investigator carrying 
out this piece of research is an employee of Naas General Hospital and 
a qualified chartered physiotherapist. She is covered under the 
indemnity of Naas General Hospital  
 
 
J3 (a) Who or what legal entity is the sponsor of this research 
study?  
  
Pending Ethical Approval from Naas General Hospital Research Ethics 
Committee 
111 
 
 
 
J3 (b) What additional indemnity arrangements has the 
sponsor put in place for this research study in case of harm 
being caused to a research participant (if any)?  
 
This research is conducted as part of the requirements of a MSc in 
Neurology and Gerontology from the Royal College of Surgeons of 
Ireland. The researcher, a registered student at RCSI is also covered by 
the indemnity by provided by RCSI 
 
 
26  
27  
28  
29  
30 SECTION k COST AND RESOURCE IMPLICATIONS and funding 
 
SECTION K IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to 
delete individual questions within each section depending on their 
response to the preceding questions.  Please respond to each question 
carefully and refer to the accompanying Guidance Manual for more in-
depth advice prior to deleting any question.   
 
 
K1 (a)  Are there any cost / resource implications related to 
this study?  No 
 
 
K2 (a) Is funding in place to conduct this study? No 
 
 
K2 (d) Is the study being funded by an external agency? No 
K2 (e) Is the external agency a ‘for profit’ organisation? No 
 
 
K2 (g) Please provide additional details in relation to 
management of funds.  
 
N/A 
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K3.  Please provide details of any payments (monetary or 
otherwise) to investigators.  
  
N/A 
 
 
K4.  Please provide details of any payments (monetary or 
otherwise) to participants.  
 
N/A 
 
 
31  
32  
33 SECTION l ETHICAL ISSUES 
 
SECTION L IS MANDATORY 
 
L1.   Please identify any particular additional ethical issues that 
this project raises and discuss how you have addressed them.  
 
The PI feels that all potential ethical issues that this project raises from 
recruitment, Consent, Data collection and protection, exclusion criteria, 
safety issues and adverse events; have all been discussed and addressed 
in various sections of the application form 
 
PLEASE ENSURE THIS APPLICATION FORM IS FULLY COMPLETED AS INCOMPLETE 
SUBMISSIONS WILL NOT BE REVIEWED.  
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Appendix 7: Ethical Approval Royal College of Surgeons of Ireland 
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Appendix 8: Adverse Events Form during Intervention Programme: 
Participant ID:_____________________ 
 
 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Explanation 
Muscle 
Soreness 
>48hrs 
       
Injury 
Sustained 
       
Near-
Miss 
Accident 
       
Fall 
Sustained 
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Appendix 9: Adverse Events Form carrying out Home Exercise Programme: 
 
Participant ID:_____________________ 
 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Muscle 
Soreness 
>48hrs 
       
Injury 
Sustained 
 
(Explain) 
       
Near-
Miss 
Accident 
 
(Explain) 
       
Fall 
Sustained 
 
(Explain) 
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Appendix 10: Exercise Compliance:  
Exercise Logbook (Home Exercise Diary and DVD Compliance Log) 
Please Circle the times of the day when you carried out your 7 Core Exercises: 
Exercises Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Ex #1 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #2 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #3 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #4 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #5 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #6 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
Ex #7 am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
am 
 
pm 
 
Please Tick the Days You Used the Exercise DVD to assist you while Exercising: 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
DVD 
USE 
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Appendix 11: Adherence Rates: Attendance Sheet 
 
Large-Amplitude Group Exercise Programme 
Attendance Sheet 
 
Participant 
ID 
Class 1 
Date: 
Class 2 
Date: 
Class 3 
Date: 
Class 4 
Date: 
Class 5 
Date: 
Class 6 
Date: 
Notes 
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Appendix 12: Participant Satisfaction:                                                                                                                  
The researcher would like to know you feedback from the exercise programme.   
Please place one tick under the statement which best reflects your answer 
 
Question 
%                                 
Strongly 
Disagree 
Disagree 
 
Neither 
Agree or 
Disagree 
Agree 
 
Strongly 
Agree 
 
I found the programme beneficial      
I found the frequency of the class 
adequate (x1/week) 
     
The duration of the class  (1 hour) 
was too long 
     
After the exercise programme, I am 
able to walk for longer distances 
     
After the exercise programme, my 
ADLs such as doing the house chores 
and shopping are easier to manage 
     
After the exercise programme, I feel 
steadier on my feet  
     
My mood has improved after 
completion of the programme 
     
The exercise resources (Photo-pack, 
DVD, YouTube link) motivated me 
to exercise at home 
     
Please Circle which Resource you 
found most beneficial: 
Photo-
Pack 
          
DVD 
 
YouTube 
Video 
                          
 None 
Of the 
Above 
 
The Home Exercise Programme was 
difficult to carry out at home because 
it was too long to carry out 
     
I will continue to practice my daily 
home exercise programme when the 
programme has finished 
     
I feel that exercising in a group 
setting is more enjoyable than 
exercising one- to -one 
(physiotherapist and individual) 
     
I would recommend this exercise 
programme to others 
     
My exercise habits are going to 
change after the programme 
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Appendix 13: Six Minute Walk Test 
Description: The 6-Minute Walk test is a measure of exercise capacity and 
endurance 
Equipment: Stopwatch, Tape Measure, Track/loop Walkway, Portable Chair 
Instructions to participant: 
 “When I say “go”, I want you to walk as quickly as you can, as  you feel 
comfortable and safe,  for six minutes, up and down this walkway, doing laps. I will 
walk with you. If you get tired, short of breath, have chest pain, leg pain, or any 
other symptoms, we will stop and have you rest until you feel ready to go again. 
While you rest, we let the stopwatch run, and then when you are through resting you 
can continue to walk for what is left of the remaining 6 minutes. You can begin when 
I say “go”. 
 Be sure to walk slightly BEHIND the participant so you are not 
unintentionally coaxing them to go faster than they would choose otherwise. 
 Inform the patient of the time elapsed at the end of each minute. 
 Keep talking to a minimum to conserve participants’ pulmonary function. 
 
At the end of the 6 minutes: 
 Have the participant sit down (portable chair). 
 Calculate and record the distance walked 
 
Time Document Distance 
Minute 1 
 
 
Minute 2 
 
 
Minute 3 
 
 
Minute 4 
 
 
Minute 5 
 
 
Minute 6 
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Appendix 14: Permission to Use MDS-UPDRS for Research Project: 
 Name: Eimear Manley 
Company / Organization Name: Naas General Hospital 
Address: Physiotherapy Department, Naas General Hospital City: Kildare State: 
Leinster  
Country: Ireland 
Telephone: 00353871257242. Email: Eimear.manley@rcsi.ie 
Intended use of materials: I am currently carrying out an MSc in the Royal College 
of Surgeons in Ireland. 
As part of my research project, I would like to use the MDS-UPDRS as one of my 
outcome measures. 
My study is a small feasibility study which aims to assess the clinical effectiveness 
and feasibility of a movement-amplitude training programme in people with 
Parkinson’s Disease. 
I am receiving no funding/grants for this small scale study.Total: $0 USD 
By submitting this request to MDS, you agree to the following:I understand that all 
of the International Parkinson and Movement Disorder Society (MDS) Rating Scales 
may only be used for the purposes described above. I also understand that 
reproduction, translation, modification, sale, or distribution of any portion of the 
MDS Rating Scales is strictly prohibited and, specifically, that the MDS Rating 
Scales may not be incorporated into clinical trials, training or certification programs 
or materials, software programs, or otherwise except through use of the Permissions 
Request form and payment of applicable fees. 
 Dear Dr. Manley, 
Thank you for contacting MDS regarding permission to use the MDS-UPDRS 
in your research project.  I have reviewed your request and am pleased to grant 
you permission to use the MDS-UPDRS in your research project, free of 
charge.  Please let me know if you have any questions or if there is anything 
further I can assist you with.  Thank you. 
 Best Regards,  
Megan Campbell 
Program Manager 
International Parkinson and Movement Disorder Society (MDS) 
555 E. Wells Street, Suite 1100 
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Milwaukee, WI 53202 
Phone: +1 (414) 276-2145 | Fax: +1 (414) 276-3349 
E-mail: mcampbell@movementdisorders.org 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
122 
 
Appendix 14: Movement-Disorder Society-Unified Parkinson’s Disease Rating Scale 
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126 
 
 
 
127 
 
 
 
128 
 
 
 
129 
 
 
 
130 
 
 
 
131 
 
 
 
132 
 
 
 
133 
 
 
 
134 
 
 
 
135 
 
 
 
136 
 
 
 
137 
 
 
 
138 
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Appendix 15: Timed Up and Go Test 
 
Directions: 
 
 The Time “Up and Go” Test measures, in seconds, the time taken for an 
individual to stand up from a standard arm chair (approximate seat height of 
46cm, arm height 65cm), walk a distance of 3 metres, turn, walk back to the 
chair and sit down.  
 The subject wears their regular footwear and uses their customary aid (none, 
cane, walker) at hand. 
 They are instructed that, on the work “go” they are to get up and walk at a 
comfortable and safe pace to a line on the floor 3 metres away, turn, return to 
the chair and sit down again. 
 The subject walks through the test once before being timed in order to 
become familiar with the test. 
 Either a stopwatch or a wristwatch with a second hand can be used to time the 
trial. 
 
Instructions to the patient: 
 
Timed Up and Go: Walk as quickly and safely as possible to the marked line, turn 
around, walk back to the chair and sit down”. 
 
 
Time: _________________________________ 
 
Mobility Aid Used: Yes/No 
 
If yes what aid: ____________________________ 
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Appendix 16: Dynamic Gait Index 
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Appendix 17: Parkinson’s Disease Questionniare 39 
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144 
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Appendix 18: Home Exercise Photo pack 
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147 
 
 
148 
 
 
149 
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Appendix 19: Exercise YouTube Link 
 
Copy/type this link into the toolbar at the top of your internet page and press enter. 
 
A YouTube link, “large-amplitude exercises for Parkinson’s Disease” should appear 
with a video of Eimear carrying out the exercises. 
 
Follow along with the video while practicing your exercises OR review the video 
first to refresh your memory and practice on your own. 
 
https://youtu.be/-ajvOIaAI2k 
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Appendix 20: Data Collection Form 
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Appendix 21: Doctor Information Letter 
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Appendix 22: Doctor Discharge Letter 
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